c-Rel	B-protein
is	O
a	O
target	O
of	O
pentoxifylline-mediated	O
inhibition	O
of	O
T	O
lymphocyte	O
activation	O
.	O

The	O
possible	O
clinical	O
use	O
of	O
the	O
methyl	O
xanthine	O
derivative	O
,	O
pentoxifylline	O
(	O
PF	O
)	O
,	O
for	O
the	O
treatment	O
of	O
T	O
cell-dependent	O
diseases	O
is	O
being	O
noted	O
with	O
increasing	O
interest	O
.	O

In	O
this	O
paper	O
,	O
we	O
studied	O
the	O
molecular	O
consequences	O
of	O
PF	O
treatment	O
during	O
lymphocyte	O
activation	O
.	O

We	O
found	O
that	O
in	O
T	B-cell_type
cells	I-cell_type
,	O
anti-CD3-induced	O
c-Rel	B-protein
expression	O
was	O
blocked	O
by	O
PF	O
,	O
whereas	O
the	O
induction	O
of	O
other	O
NF-kappaB	B-protein
family	I-protein
members	I-protein
was	O
not	O
significantly	O
affected	O
.	O

However	O
,	O
induction	O
of	O
NF-AT	B-protein
,	O
which	O
has	O
the	O
same	O
signaling	O
requirements	O
as	O
c-Rel	B-protein
induction	O
,	O
was	O
not	O
inhibited	O
by	O
PF	O
.	O

Among	O
genes	O
that	O
respond	O
to	O
these	O
transcription	B-protein
factors	I-protein
,	O
IL-2	B-RNA
mRNA	I-RNA
induction	O
was	O
suppressed	O
by	O
PF	O
,	O
whereas	O
IL-2R	B-RNA
(	I-RNA
alpha	I-RNA
)	I-RNA
chain	I-RNA
mRNA	I-RNA
induction	O
was	O
not	O
affected	O
.	O

These	O
observations	O
implicated	O
c-Rel	B-protein
as	O
an	O
IL-2	B-protein
promoter	I-protein
factor	I-protein
,	O
for	O
which	O
experimental	O
support	O
was	O
obtained	O
from	O
transient	O
transfection	O
experiments	O
.	O

In	O
contrast	O
with	O
the	O
observation	O
in	O
T	B-cell_type
cells	I-cell_type
,	O
c-Rel	B-protein
induction	O
was	O
not	O
blocked	O
by	O
PF	O
in	O
B	B-cell_type
cells	I-cell_type
.	O

The	O
greater	O
selectivity	O
of	O
PF	O
,	O
compared	O
with	O
FK506	O
,	O
at	O
both	O
the	O
molecular	O
and	O
cellular	O
levels	O
may	O
prove	O
advantageous	O
in	O
manipulating	O
T	O
cell	O
responses	O
in	O
vivo	O
.	O

Immunity	NULL
,	NULL
Vol	NULL
.	NULL

6	NULL
,	NULL
165-174	NULL
,	NULL
February	NULL
,	NULL
1997	NULL
,	NULL
Copyright	NULL
©1997	NULL
by	NULL
Cell	NULL
Press	NULL
c-Rel	NULL
Is	NULL
a	NULL
Target	NULL
of	NULL
Pentoxifylline-Mediated	NULL
Inhibition	NULL
of	NULL
T	NULL
Lymphocyte	NULL
Activation	NULL
Weihong	NULL
Wang	NULL
,	NULL
*	NULL
Winnie	NULL
F.	NULL
Tam	NULL
,	NULL
*	NULL
Christopher	NULL
C.	NULL
W.	NULL
Hughes	NULL
,	NULL
+	NULL
Satyajit	NULL
Rath	NULL
,	NULL
t	NULL
and	NULL
Ranjan	NULL
Sen*	NULL
*Rosenstiel	NULL
Basic	NULL
Medical	NULL
Sciences	NULL
Research	NULL
Center	NULL
and	NULL
Department	NULL
of	NULL
Biology	NULL
Brandeis	NULL
University	NULL
Waltham	NULL
,	NULL
Massachusetts	NULL
02254	NULL
TtNational	NULL
Institute	NULL
of	NULL
Immunology	NULL
Aruna	NULL
Asaf	NULL
Ali	NULL
Marg	NULL
New	NULL
Delhi	NULL
India	NULL
*Department	NULL
of	NULL
Molecular	NULL
Biology	NULL
and	NULL
Biochemistry	NULL
Bio	NULL
Sci	NULL
II	NULL
University	NULL
of	NULL
California	NULL
at	NULL
Irvine	NULL
Irvine	NULL
,	NULL
California	NULL
92717	NULL
Summary	NULL
The	NULL
possible	NULL
clinical	NULL
use	NULL
of	NULL
the	NULL
methyl	NULL
xanthine	NULL
deriva-tive	NULL
,	NULL
pentoxifylline	NULL
(	NULL
PF	NULL
)	NULL
,	NULL
for	NULL
the	NULL
treatment	NULL
of	NULL
T	NULL
cell-dependent	NULL
diseases	NULL
is	NULL
being	NULL
noted	NULL
with	NULL
increasing	NULL
interest	NULL
.	NULL

In	NULL
this	NULL
paper	NULL
,	NULL
we	NULL
studied	NULL
the	NULL
molecular	NULL
consequences	NULL
of	NULL
PF	NULL
treatment	NULL
during	NULL
lymphocyte	NULL
activation	NULL
.	NULL

We	NULL
found	NULL
that	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
anti-CD3-induced	NULL
c-Rel	NULL
expression	NULL
was	NULL
blocked	NULL
by	NULL
PF	NULL
,	NULL
whereas	NULL
the	NULL
induction	NULL
of	NULL
other	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
members	NULL
was	NULL
not	NULL
significantly	NULL
affected	NULL
.	NULL

However	NULL
,	NULL
induction	NULL
of	NULL
NF-AT	NULL
,	NULL
which	NULL
has	NULL
the	NULL
same	NULL
signaling	NULL
requirements	NULL
as	NULL
c-Rel	NULL
induction	NULL
,	NULL
was	NULL
not	NULL
inhibited	NULL
by	NULL
PF	NULL
.	NULL

Among	NULL
genes	NULL
that	NULL
respond	NULL
to	NULL
these	NULL
transcription	NULL
factors	NULL
,	NULL
IL-2	NULL
mRNA	NULL
induction	NULL
was	NULL
suppressed	NULL
by	NULL
PF	NULL
,	NULL
whereas	NULL
IL-2Ra	NULL
«	NULL
chain	NULL
mRNA	NULL
induction	NULL
was	NULL
not	NULL
affected	NULL
.	NULL

These	NULL
observations	NULL
implicated	NULL
c-Rel	NULL
as	NULL
an	NULL
IL-2	NULL
promoter	NULL
factor	NULL
,	NULL
for	NULL
which	NULL
experimental	NULL
support	NULL
was	NULL
obtained	NULL
from	NULL
transient	NULL
transfection	NULL
experiments	NULL
.	NULL

In	NULL
contrast	NULL
with	NULL
the	NULL
observation	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
c-Rel	NULL
induction	NULL
was	NULL
not	NULL
blocked	NULL
by	NULL
PF	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
greater	NULL
selectivity	NULL
of	NULL
PF	NULL
,	NULL
compared	NULL
with	NULL
FK506	NULL
,	NULL
at	NULL
both	NULL
the	NULL
molecular	NULL
and	NULL
cellular	NULL
levels	NULL
may	NULL
prove	NULL
advantageous	NULL
in	NULL
manipulating	NULL
T	NULL
cell	NULL
responses	NULL
in	NULL
vivo	NULL
.	NULL

Introduction	NULL
Lymphocyte	NULL
activation	NULL
via	NULL
the	NULL
antigen	NULL
receptors	NULL
results	NULL
in	NULL
clonal	NULL
expansion	NULL
and	NULL
differentiation	NULL
that	NULL
is	NULL
critical	NULL
for	NULL
subsequent	NULL
immune	NULL
responses	NULL
.	NULL

Signals	NULL
initiated	NULL
at	NULL
the	NULL
plasma	NULL
membrane	NULL
culminate	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
transcription	NULL
factors	NULL
that	NULL
reprogram	NULL
cellular	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
induction	NULL
patterns	NULL
of	NULL
two	NULL
factors	NULL
,	NULL
NF-AT	NULL
and	NULL
c-Rel	NULL
,	NULL
correlate	NULL
most	NULL
closely	NULL
with	NULL
proliferation	NULL
of	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
,	NULL
because	NULL
both	NULL
proteins	NULL
are	NULL
induced	NULL
only	NULL
in	NULL
response	NULL
to	NULL
the	NULL
``	NULL
complete	NULL
``	NULL
proliferative	NULL
signal	NULL
provided	NULL
by	NULL
the	NULL
combined	NULL
action	NULL
of	NULL
phorbol	NULL
ester	NULL
and	NULL
a	NULL
calcium	NULL
ionophore	NULL
,	NULL
such	NULL
as	NULL
ionomycin	NULL
(	NULL
Utz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Venkataraman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Their	NULL
importance	NULL
in	NULL
lymphocyte	NULL
function	NULL
is	NULL
further	NULL
highlighted	NULL
by	NULL
the	NULL
observation	NULL
that	NULL
induction	NULL
of	NULL
both	NULL
factors	NULL
is	NULL
suppressed	NULL
by	NULL
the	NULL
immunosuppressive	NULL
drugs	NULL
cyclosporin	NULL
A	NULL
and	NULL
FK506	NULL
(	NULL
Emme	NULL
!	NULL

et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Venkataraman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
lymphocyte	NULL
proliferation	NULL
in	NULL
response	NULL
to	NULL
antigen	NULL
receptor	NULL
signals	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
severely	NULL
inhibited	NULL
in	NULL
c-Rel-deficient	NULL
mice	NULL
(	NULL
Kontgen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
drugs	NULL
affecting	NULL
c-Rel	NULL
and	NULL
NF-AT	NULL
induction	NULL
will	NULL
provide	NULL
a	NULL
means	NULL
of	NULL
regulating	NULL
lymphocyte	NULL
activation	NULL
for	NULL
therapeutic	NULL
purposes	NULL
.	NULL

Pentoxifylline	NULL
(	NULL
PF	NULL
)	NULL
is	NULL
a	NULL
vasoactive	NULL
drug	NULL
that	NULL
is	NULL
widely	NULL
used	NULL
in	NULL
the	NULL
clinic	NULL
as	NULL
an	NULL
anti-inflammatory	NULL
and	NULL
for	NULL
the	NULL
treatment	NULL
of	NULL
endotoxin	NULL
shock	NULL
.	NULL

Although	NULL
its	NULL
efficacy	NULL
has	NULL
been	NULL
attributed	NULL
primarily	NULL
to	NULL
the	NULL
inhibition	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
(	NULL
TNFa	NULL
)	NULL
production	NULL
by	NULL
monocytes	NULL
and	NULL
macro-phages	NULL
(	NULL
Streiter	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
,	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
PF	NULL
affects	NULL
diverse	NULL
cell	NULL
types	NULL
.	NULL

For	NULL
example	NULL
,	NULL
effects	NULL
have	NULL
been	NULL
noted	NULL
on	NULL
endothelial	NULL
cells	NULL
(	NULL
Kovach	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Tozawa	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
smooth	NULL
muscle	NULL
cells	NULL
(	NULL
Bellas	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
fibrosarcoma	NULL
cell	NULL
lines	NULL
(	NULL
Takahashi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
,	NULL
neuroblastoma	NULL
cells	NULL
(	NULL
Yang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
embryonic	NULL
kidney	NULL
cells	NULL
(	NULL
Biswas	NULL
et	NULL
al	NULL
.	NULL

,	NULL
19933	NULL
)	NULL
,	NULL
and	NULL
lymphocytes	NULL
(	NULL
Biswas	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993b	NULL
;	NULL
Tozawa	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
known	NULL
effects	NULL
on	NULL
lymphocytes	NULL
are	NULL
briefly	NULL
described	NULL
below	NULL
.	NULL

Injection	NULL
of	NULL
anti-CD3	NULL
antibodies	NULL
in	NULL
vivo	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
TNFa	NULL
as	NULL
well	NULL
as	NULL
soluble	NULL
TNF	NULL
receptors	NULL
.	NULL

PF	NULL
reduced	NULL
systemic	NULL
TNFa	NULL
and	NULL
p75	NULL
TNF	NULL
receptor	NULL
levels	NULL
,	NULL
suggesting	NULL
that	NULL
it	NULL
interfered	NULL
with	NULL
the	NULL
anti-CD3	NULL
activation	NULL
pathways	NULL
(	NULL
Bemelmans	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
two	NULL
rodent	NULL
autoimmune	NULL
models	NULL
,	NULL
PF	NULL
conferred	NULL
significant	NULL
protection	NULL
against	NULL
disease	NULL
progression	NULL
.	NULL

Immunization	NULL
with	NULL
myelin	NULL
basic	NULL
protein	NULL
induces	NULL
experimental	NULL
autoimmune	NULL
encephalomyelitis	NULL
in	NULL
rats	NULL
,	NULL
which	NULL
is	NULL
characterized	NULL
by	NULL
loss	NULL
of	NULL
weight	NULL
and	NULL
paralysis	NULL
of	NULL
hind	NULL
legs	NULL
.	NULL

These	NULL
disease	NULL
symptoms	NULL
were	NULL
almost	NULL
completely	NULL
abolished	NULL
by	NULL
PF	NULL
administration	NULL
(	NULL
Rott	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
mercuric	NULL
chloride	NULL
induced	NULL
arthritis	NULL
in	NULL
rats	NULL
,	NULL
which	NULL
is	NULL
a	NULL
model	NULL
of	NULL
a	NULL
Th2-type	NULL
T	NULL
cell	NULL
disease	NULL
,	NULL
was	NULL
also	NULL
significantly	NULL
decreased	NULL
by	NULL
PF	NULL
(	NULL
Kiley	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
not	NULL
only	NULL
suggest	NULL
that	NULL
PF	NULL
may	NULL
be	NULL
an	NULL
excellent	NULL
therapeutic	NULL
agent	NULL
to	NULL
control	NULL
aberrant	NULL
T	NULL
cell	NULL
responses	NULL
,	NULL
but	NULL
also	NULL
indicate	NULL
that	NULL
PF	NULL
may	NULL
have	NULL
significant	NULL
immunomodulatory	NULL
effects	NULL
when	NULL
administered	NULL
for	NULL
other	NULL
reasons	NULL
.	NULL

Because	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
signaling	NULL
pathways	NULL
affected	NULL
by	NULL
PF	NULL
,	NULL
we	NULL
were	NULL
prompted	NULL
to	NULL
initiate	NULL
a	NULL
systematic	NULL
analysis	NULL
of	NULL
the	NULL
molecular	NULL
consequences	NULL
of	NULL
PF	NULL
treatment	NULL
.	NULL

Our	NULL
interest	NULL
in	NULL
PF	NULL
originated	NULL
from	NULL
a	NULL
proposed	NULL
connection	NULL
between	NULL
NF-kB	NULL
and	NULL
this	NULL
drug	NULL
in	NULL
various	NULL
cell	NULL
types	NULL
.	NULL

In	NULL
early	NULL
studies	NULL
,	NULL
activation	NULL
of	NULL
the	NULL
HIV	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
in	NULL
293	NULL
embryonic	NULL
kidney	NULL
cells	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
diminished	NULL
by	NULL
nontoxic	NULL
doses	NULL
of	NULL
PF	NULL
(	NULL
Biswas	NULL
et	NULL
al	NULL
.	NULL

,	NULL
19933	NULL
)	NULL
.	NULL

Because	NULL
induced	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
depends	NULL
on	NULL
two	NULL
NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
in	NULL
the	NULL
enhancer	NULL
region	NULL
,	NULL
these	NULL
observations	NULL
suggested	NULL
that	NULL
NF-B-dependent	NULL
transcription	NULL
was	NULL
a	NULL
target	NULL
of	NULL
PF	NULL
.	NULL

Biswas	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1993b	NULL
)	NULL
extended	NULL
their	NULL
analysis	NULL
to	NULL
Jurkat	NULL
cells	NULL
,	NULL
where	NULL
a	NULL
50	NULL
%	NULL
decrease	NULL
in	NULL
DNA	NULL
binding	NULL
was	NULL
seen	NULL
when	NULL
the	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
phorbol	NULL
ester	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PF	NULL
.	NULL

More	NULL
recently	NULL
,	NULL
Bellas	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
reported	NULL
that	NULL
smooth	NULL
muscle	NULL
cells	NULL
from	NULL
bovine	NULL
aorta	NULL
contained	NULL
constitutive	NULL
nuclear	NULL
DNA-binding	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
which	NULL
was	NULL
reflected	NULL
in	NULL
transcriptional	NULL
activity	NULL
of	NULL
a	NULL
transfected	NULL
c-myc	NULL
promoter-directed	NULL
reporter	NULL
gene	NULL
.	NULL

Immunity	NULL
166	NULL
Treatment	NULL
of	NULL
these	NULL
cells	NULL
with	NULL
PF	NULL
decreased	NULL
c-myc	NULL
promoter	NULL
activity	NULL
approximately	NULL
2-fold	NULL
.	NULL

Although	NULL
NF-kB	NULL
levels	NULL
were	NULL
not	NULL
directly	NULL
assessed	NULL
,	NULL
these	NULL
results	NULL
were	NULL
consistent	NULL
with	NULL
the	NULL
interpretation	NULL
that	NULL
decreased	NULL
c-myc	NULL
promoter	NULL
activity	NULL
may	NULL
be	NULL
due	NULL
to	NULL
reduction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
PF	NULL
.	NULL

Finally	NULL
,	NULL
PF	NULL
was	NULL
shown	NULL
to	NULL
block	NULL
the	NULL
binding	NULL
of	NULL
human	NULL
cancer	NULL
cells	NULL
to	NULL
vascular	NULL
endothelial	NULL
cells	NULL
(	NULL
Tozawa	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

This	NULL
interaction	NULL
is	NULL
mediated	NULL
by	NULL
several	NULL
endothelial	NULL
cell	NULL
adhesion	NULL
molecules	NULL
such	NULL
as	NULL
ICAM-1	NULL
,	NULL
VCAM-1	NULL
,	NULL
and	NULL
E-selectin	NULL
whose	NULL
expression	NULL
is	NULL
believed	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
NF-kB	NULL
proteins	NULL
(	NULL
Ledebur	NULL
and	NULL
Parks	NULL
,	NULL
1995	NULL
;	NULL
Montgomery	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Neish	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Schindler	NULL
and	NULL
Baichwal	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
we	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
PF	NULL
on	NULL
lymphocyte	NULL
activation	NULL
.	NULL

In	NULL
T	NULL
cells	NULL
we	NULL
found	NULL
that	NULL
c-Rel	NULL
induction	NULL
,	NULL
which	NULL
requires	NULL
the	NULL
dual	NULL
signal	NULL
of	NULL
phorbol	NULL
ester	NULL
and	NULL
ionomycin	NULL
or	NULL
anti-CD3	NULL
treatment	NULL
,	NULL
was	NULL
suppressed	NULL
by	NULL
PF	NULL
.	NULL

This	NULL
effect	NULL
was	NULL
not	NULL
a	NULL
common	NULL
feature	NULL
of	NULL
all	NULL
Rel	NULL
family	NULL
members	NULL
because	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
p50/p65	NULL
heterodimer	NULL
)	NULL
was	NULL
variably	NULL
affected	NULL
,	NULL
and	NULL
Rel	NULL
B	NULL
was	NULL
not	NULL
affected	NULL
at	NULL
all	NULL
by	NULL
this	NULL
drug	NULL
.	NULL

In	NULL
its	NULL
effects	NULL
on	NULL
NF-kB	NULL
family	NULL
proteins	NULL
,	NULL
we	NULL
found	NULL
PF	NULL
treatment	NULL
to	NULL
be	NULL
indistinguishable	NULL
from	NULL
our	NULL
earlier	NULL
analysis	NULL
of	NULL
the	NULL
immunosuppressive	NULL
drug	NULL
FK506	NULL
(	NULL
Venkataraman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
contrast	NULL
with	NULL
cyclosporin	NULL
A	NULL
or	NULL
FK506	NULL
,	NULL
PF	NULL
treatment	NULL
did	NULL
not	NULL
suppress	NULL
NF-AT	NULL
induction	NULL
or	NULL
NF-AT-dependent	NULL
transcription	NULL
activation	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

Because	NULL
c-Rel	NULL
induction	NULL
,	NULL
like	NULL
NF-AT	NULL
,	NULL
requires	NULL
a	NULL
calcineurin-dependent	NULL
step	NULL
,	NULL
these	NULL
observations	NULL
suggest	NULL
that	NULL
PF	NULL
affects	NULL
c-Rel	NULL
induction	NULL
downstream	NULL
of	NULL
calcineurin	NULL
.	NULL

Suppression	NULL
of	NULL
some	NULL
,	NULL
but	NULL
not	NULL
all	NULL
,	NULL
inducible	NULL
transcription	NULL
factors	NULL
was	NULL
reflected	NULL
in	NULL
inhibition	NULL
of	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
gene	NULL
expression	NULL
,	NULL
but	NULL
not	NULL
interleukin-2	NULL
receptor	NULL
«	NULL
chain	NULL
(	NULL
IL-2Ra	NULL
)	NULL
gene	NULL
induction	NULL
.	NULL

Interestingly	NULL
,	NULL
c-Rel	NULL
induction	NULL
in	NULL
B	NULL
cells	NULL
activated	NULL
by	NULL
phorbol	NULL
ester	NULL
and	NULL
ionomycin	NULL
was	NULL
not	NULL
blocked	NULL
by	NULL
PF	NULL
,	NULL
suggesting	NULL
that	NULL
PF	NULL
may	NULL
differentially	NULL
affect	NULL
B	NULL
and	NULL
T	NULL
cell	NULL
responses	NULL
.	NULL

Anti-CD3+PF	NULL
Anti-CD3+FK506	NULL
Untreated	NULL
Anti-CD3	NULL
Anti-CD3+FK506	NULL
Untreated	NULL
Anti-CD3	NULL
Anti-CD3+PF	NULL
<	NULL
-	NULL
NF-AT	NULL
<	NULL
-	NULL
NF-xB	NULL
t	NULL
1	NULL
2	NULL
3	NULL
4	NULL
1	NULL
2	NULL
3	NULL
4	NULL
Untreated	NULL
Anti-CD3	NULL
Anti-CD3+FK506	NULL
Anti-CD3+PF	NULL
<	NULL
-AP-	NULL
1020	NULL
3	NULL
4	NULL
<	NULL
-	NULL
NF-ATp	NULL
Results	NULL
PF	NULL
Inhibits	NULL
NF-	NULL
«	NULL
B	NULL
Induction	NULL
in	NULL
D5h3	NULL
(	NULL
T	NULL
)	NULL
Cells	NULL
To	NULL
investigate	NULL
the	NULL
effects	NULL
of	NULL
PF	NULL
on	NULL
lymphocytes	NULL
,	NULL
we	NULL
activated	NULL
D5h3	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
drug	NULL
and	NULL
assayed	NULL
the	NULL
induction	NULL
of	NULL
transcription	NULL
factors	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSA	NULL
)	NULL
and	NULL
immunoblotting	NULL
.	NULL

Activation	NULL
by	NULL
anti-CD3	NULL
cross-linking	NULL
or	NULL
by	NULL
treatment	NULL
with	NULL
phorbol	NULL
ester	NULL
and	NULL
ionomycin	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
strongly	NULL
induced	NULL
NF-kB	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
Figure	NULL
1A	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
by	NULL
antibody	NULL
supershifts	NULL
that	NULL
this	NULL
induced	NULL
complex	NULL
contains	NULL
both	NULL
p65	NULL
(	NULL
Rel	NULL
A	NULL
)	NULL
and	NULL
c-Rel	NULL
proteins	NULL
(	NULL
Venkataraman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
difficult	NULL
to	NULL
estimate	NULL
accurately	NULL
the	NULL
proportion	NULL
of	NULL
the	NULL
available	NULL
nuclear	NULL
DNA	NULL
binding	NULL
activity	NULL
that	NULL
is	NULL
either	NULL
the	NULL
p50/p65	NULL
or	NULL
p50/c-Rel	NULL
heterodim-ers	NULL
,	NULL
because	NULL
these	NULL
proteins	NULL
have	NULL
different	NULL
affinities	NULL
for	NULL
the	NULL
probe	NULL
DNA	NULL
and	NULL
the	NULL
antisera	NULL
recognize	NULL
the	NULL
DNA-bound	NULL
proteins	NULL
with	NULL
different	NULL
efficiencies	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
PF	NULL
(	NULL
Figure	NULL
1A	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
or	NULL
the	NULL
immunosuppressive	NULL
drug	NULL
FK506	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
induction	NULL
of	NULL
proteins	NULL
binding	NULL
to	NULL
this	NULL
kB	NULL
DNA	NULL
probe	NULL
was	NULL
significantly	NULL
reduced	NULL
.	NULL

In	NULL
the	NULL
experiments	NULL
described	NULL
above	NULL
,	NULL
PF	NULL
and	NULL
FK506	NULL
affected	NULL
the	NULL
induction	NULL
of	NULL
NF-kB	NULL
proteins	NULL
similarly	NULL
.	NULL

To	NULL
extend	NULL
these	NULL
observations	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
PF	NULL
on	NULL
two	NULL
other	NULL
well-characterized	NULL
activated	NULL
T	NULL
cell	NULL
factors	NULL
.	NULL

Unlike	NULL
NF-kB	NULL
,	NULL
induction	NULL
of	NULL
NF-AT	NULL
by	NULL
anti-CD3	NULL
(	NULL
Figure	NULL
1B	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
PF	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
NF-AT	NULL
induction	NULL
was	NULL
abolished	NULL
by	NULL
FK506	NULL
(	NULL
Figure	NULL
1B	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
neither	NULL
PF	NULL
nor	NULL
FK506	NULL
had	NULL
any	NULL
effect	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
AP-1	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
Figure	NULL
1C	NULL
)	NULL
.	NULL

In	NULL
these	NULL
assays	NULL
,	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
FK506	NULL
or	NULL
PF	NULL
alone	NULL
(	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
cell	NULL
stimulation	NULL
)	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
constitutive	NULL
levels	NULL
of	NULL
NF-kB	NULL
or	NULL
NF-AT	NULL
protein	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
indicate	NULL
that	NULL
PF	NULL
and	NULL
FK506	NULL
differentially	NULL
affect	NULL
inducible	NULL
nuclear	NULL
factors	NULL
in	NULL
activated	NULL
D5h3	NULL
cells	NULL
;	NULL
FK506	NULL
blocks	NULL
c-Rel	NULL
and	NULL
NF-AT	NULL
induction	NULL
,	NULL
Figure	NULL
1	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
Effects	NULL
of	NULL
PF	NULL
and	NULL
FK506	NULL
on	NULL
Activation	NULL
of	NULL
Inducible	NULL
Transcription	NULL
Factors	NULL
in	NULL
D5h3	NULL
T	NULL
Cells	NULL
{	NULL
A	NULL
)	NULL
Analysis	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
D5h3	NULL
cells	NULL
treated	NULL
as	NULL
indicated	NULL
above	NULL
the	NULL
lanes	NULL
.	NULL

Anti-CD3	NULL
refers	NULL
to	NULL
activation	NULL
of	NULL
cells	NULL
by	NULL
plate-bound	NULL
anti-CD3	NULL
antibodies	NULL
for	NULL
4	NULL
hr	NULL
.	NULL

Drugs	NULL
were	NULL
added	NULL
to	NULL
the	NULL
cells	NULL
10	NULL
min	NULL
prior	NULL
to	NULL
cell	NULL
activation	NULL
.	NULL

EMSA	NULL
analysis	NULL
was	NULL
carried	NULL
out	NULL
using	NULL
a	NULL
palindromic	NULL
NF-	NULL
«	NULL
B-binding	NULL
site	NULL
from	NULL
the	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
|	NULL
gene	NULL
pro-moter	NULL
;	NULL
this	NULL
sequence	NULL
is	NULL
referred	NULL
to	NULL
as	NULL
the	NULL
H2K	NULL
probe	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
the	NULL
position	NULL
of	NULL
the	NULL
major	NULL
inducible	NULL
NF-kB	NULL
complex	NULL
,	NULL
which	NULL
contains	NULL
both	NULL
p50/p65	NULL
and	NULL
p50/c-Rel	NULL
heterodimers	NULL
.	NULL

The	NULL
lower	NULL
,	NULL
unlabeled	NULL
band	NULL
contains	NULL
p50/p50	NULL
homodimers	NULL
.	NULL

{	NULL
B	NULL
)	NULL
Analysis	NULL
of	NULL
NF-AT	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
D5h3	NULL
nuclear	NULL
extracts	NULL
.	NULL

NF-AT	NULL
probe	NULL
is	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
NF-AT-binding	NULL
site	NULL
from	NULL
the	NULL
murine	NULL
IL-2	NULL
gene	NULL
promoter	NULL
.	NULL

The	NULL
upper	NULL
arrow	NULL
(	NULL
labeled	NULL
NF-AT	NULL
)	NULL
is	NULL
the	NULL
major	NULL
inducible	NULL
complex	NULL
that	NULL
contains	NULL
both	NULL
the	NULL
NF-AT	NULL
,	NULL
,	NULL
cytoplasmic	NULL
component	NULL
and	NULL
the	NULL
AP-1	NULL
component	NULL
.	NULL

The	NULL
lower	NULL
arrow	NULL
(	NULL
labeled	NULL
NF-AT	NULL
,	NULL
)	NULL
contains	NULL
only	NULL
the	NULL
preexisting	NULL
NF-AT	NULL
subunits	NULL
without	NULL
the	NULL
AP-1	NULL
components	NULL
.	NULL

{	NULL
C	NULL
)	NULL
Analysis	NULL
of	NULL
AP-1	NULL
binding	NULL
activity	NULL
in	NULL
D5h3	NULL
nuclear	NULL
extracts	NULL
.	NULL

An	NULL
oligonucleotide	NULL
-	NULL
(	NULL
TCGACCCACATTAGCATGACTCATTIGTTTCTGC	NULL
)	NULL
containing	NULL
the	NULL
AP-1	NULL
site	NULL
from	NULL
the	NULL
metallothioenine	NULL
gene	NULL
promoter	NULL
was	NULL
used	NULL
in	NULL
EMSA	NULL
with	NULL
extracts	NULL
derived	NULL
from	NULL
D5h3	NULL
cells	NULL
treated	NULL
in	NULL
various	NULL
ways	NULL
.	NULL

The	NULL
major	NULL
inducible	NULL
complex	NULL
is	NULL
labeled	NULL
as	NULL
AP-1	NULL
to	NULL
the	NULL
right	NULL
of	NULL
the	NULL
gel	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
the	NULL
slower	NULL
mobility	NULL
complex	NULL
present	NULL
equally	NULL
in	NULL
all	NULL
lanes	NULL
is	NULL
presently	NULL
unknown	NULL
.	NULL

Regulation	NULL
of	NULL
Rel	NULL
Proteins	NULL
in	NULL
Lymphocytes	NULL
Untreated	NULL
Anti-CD3	NULL
Anti-CD3+PF	NULL
Anti-CD3+FK506	NULL
Untreated	NULL
Anti-CD3	NULL
N	NULL
C	NULL
N	NULL
C	NULL
N	NULL
C	NULL
N	NULL
C	NULL
N	NULL
C	NULL
N	NULL
C	NULL
101	NULL
e	NULL
__	NULL
51	NULL
101	NULL
83	NULL
~-	NULL
>	NULL
51	NULL
a	NULL
_	NULL
-s	NULL
a_	NULL
-	NULL
<	NULL
-	NULL
c-Rel	NULL
35	NULL
-	NULL
35	NULL
Anti-CD3+PF	NULL
C	NULL
~-	NULL
cae	NULL
--	NULL
atte	NULL
--	NULL
ee	NULL
<	NULL
4-Rel	NULL
B	NULL
Figure	NULL
2	NULL
.	NULL

Effect	NULL
of	NULL
PF	NULL
and	NULL
FK506	NULL
on	NULL
individual	NULL
Rel	NULL
Family	NULL
Proteins	NULL
Analysis	NULL
of	NULL
c-Rel	NULL
induction	NULL
in	NULL
D5h3	NULL
cells	NULL
treated	NULL
as	NULL
indicated	NULL
above	NULL
the	NULL
lanes	NULL
.	NULL

Cell	NULL
treatments	NULL
are	NULL
summarized	NULL
in	NULL
the	NULL
legend	NULL
of	NULL
Figure	NULL
1	NULL
.	NULL

Nuclear	NULL
(	NULL
N	NULL
)	NULL
and	NULL
cytoplasmic	NULL
(	NULL
C	NULL
)	NULL
extracts	NULL
(	NULL
6	NULL
g	NULL
)	NULL
were	NULL
fractionated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
paper	NULL
,	NULL
and	NULL
probed	NULL
using	NULL
an	NULL
anti-c-Rel	NULL
antiserum	NULL
(	NULL
A	NULL
)	NULL
or	NULL
an	NULL
anti-Rel	NULL
B	NULL
antiserum	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Arrows	NULL
indicate	NULL
the	NULL
positions	NULL
of	NULL
c-Rel	NULL
and	NULL
Rel	NULL
B	NULL
proteins	NULL
.	NULL

Anti-CD3+FK506	NULL
N	NULL
C	NULL
10	NULL
20	NULL
3	NULL
4	NULL
50	NULL
60	NULL
7	NULL
8	NULL
3	NULL
4	NULL
50	NULL
60	NULL
7	NULL
8	NULL
but	NULL
not	NULL
induction	NULL
of	NULL
AP-1	NULL
,	NULL
whereas	NULL
PF	NULL
is	NULL
more	NULL
specific	NULL
and	NULL
blocks	NULL
only	NULL
the	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
but	NULL
not	NULL
NF-AT	NULL
.	NULL

Induction	NULL
of	NULL
specific	NULL
Rel	NULL
family	NULL
members	NULL
was	NULL
further	NULL
monitored	NULL
by	NULL
immunoblotting	NULL
.	NULL

c-Rel	NULL
expression	NULL
was	NULL
induced	NULL
in	NULL
both	NULL
the	NULL
cytoplasm	NULL
and	NULL
the	NULL
nucleus	NULL
by	NULL
anti-CD3	NULL
treatment	NULL
(	NULL
Figure	NULL
2A	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
and	NULL
was	NULL
abrogated	NULL
by	NULL
both	NULL
PF	NULL
and	NULL
FK506	NULL
(	NULL
lanes	NULL
5-8	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Rel	NULL
B	NULL
expression	NULL
in	NULL
the	NULL
nucleus	NULL
was	NULL
not	NULL
significantly	NULL
affected	NULL
by	NULL
activation	NULL
,	NULL
either	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
drugs	NULL
(	NULL
Figure	NULL
2B	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
activation	NULL
of	NULL
these	NULL
cells	NULL
increased	NULL
total	NULL
cellular	NULL
Rel	NULL
B	NULL
expression	NULL
,	NULL
but	NULL
most	NULL
of	NULL
the	NULL
protein	NULL
remained	NULL
in	NULL
the	NULL
cytoplasmic	NULL
fraction	NULL
(	NULL
Figure	NULL
2B	NULL
,	NULL
lanes	NULL
4	NULL
,	NULL
6	NULL
,	NULL
and	NULL
8	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
Rel	NULL
B	NULL
nuclear	NULL
translocation	NULL
required	NULL
additional	NULL
signals	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
c-Rel	NULL
induction	NULL
in	NULL
activated	NULL
D5h3	NULL
cells	NULL
is	NULL
inhibited	NULL
by	NULL
PF	NULL
,	NULL
whereas	NULL
Rel	NULL
B	NULL
induction	NULL
is	NULL
not	NULL
affected	NULL
.	NULL

Thus	NULL
,	NULL
PF	NULL
blocks	NULL
the	NULL
induction	NULL
of	NULL
a	NULL
subset	NULL
of	NULL
Rel	NULL
family	NULL
members	NULL
.	NULL

Properties	NULL
of	NULL
NF-AT	NULL
in	NULL
PF-Treated	NULL
D5h3	NULL
Cells	NULL
To	NULL
investigate	NULL
further	NULL
the	NULL
apparent	NULL
lack	NULL
of	NULL
effect	NULL
of	NULL
PF	NULL
on	NULL
NF-AT	NULL
induction	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
subunit	NULL
composition	NULL
and	NULL
transcription	NULL
activation	NULL
properties	NULL
of	NULL
NF-AT	NULL
in	NULL
PF-treated	NULL
cells	NULL
.	NULL

In	NULL
EMSA	NULL
,	NULL
most	NULL
of	NULL
the	NULL
anti-CD3	NULL
induced	NULL
NF-AT	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
PF	NULL
was	NULL
supershifted	NULL
with	NULL
antisera	NULL
directed	NULL
against	NULL
NF-AT	NULL
,	NULL
(	NULL
Figure	NULL
3A	NULL
,	NULL
compare	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
with	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Both	NULL
upper	NULL
and	NULL
lower	NULL
NF-AT	NULL
complexes	NULL
were	NULL
significantly	NULL
diminished	NULL
,	NULL
giving	NULL
rise	NULL
to	NULL
two	NULL
new	NULL
bands	NULL
whose	NULL
positions	NULL
are	NULL
indicated	NULL
by	NULL
the	NULL
arrows	NULL
on	NULL
the	NULL
side	NULL
of	NULL
the	NULL
gel	NULL
(	NULL
Figure	NULL
3A	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
bulk	NULL
of	NULL
the	NULL
activity	NULL
being	NULL
NF-AT	NULL
,	NULL
derived	NULL
,	NULL
the	NULL
NF-AT	NULL
,	NULL
antisera	NULL
did	NULL
not	NULL
yield	NULL
significant	NULL
supershifted	NULL
complexes	NULL
(	NULL
Figure	NULL
3A	NULL
,	NULL
compare	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
with	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Longer	NULL
exposures	NULL
of	NULL
these	NULL
gels	NULL
revealed	NULL
weak	NULL
supershift	NULL
bands	NULL
that	NULL
were	NULL
not	NULL
significantly	NULL
different	NULL
in	NULL
the	NULL
two	NULL
sets	NULL
of	NULL
extracts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
residual	NULL
slower	NULL
migrating	NULL
complex	NULL
left	NULL
at	NULL
the	NULL
position	NULL
of	NULL
the	NULL
NF-AT-DNA	NULL
complex	NULL
after	NULL
anti-NF-AT	NULL
,	NULL
treatment	NULL
represents	NULL
NF-AT	NULL
;	NULL
containing	NULL
induced	NULL
proteins	NULL
.	NULL

Comparison	NULL
of	NULL
this	NULL
complex	NULL
in	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
confirmed	NULL
that	NULL
the	NULL
levels	NULL
of	NULL
NF-AT	NULL
;	NULL
were	NULL
also	NULL
not	NULL
affected	NULL
by	NULL
PF	NULL
treatment	NULL
.	NULL

The	NULL
transcription	NULL
activation	NULL
properties	NULL
of	NULL
NF-AT	NULL
were	NULL
examined	NULL
by	NULL
transient	NULL
transfection	NULL
assays	NULL
using	NULL
reporter	NULL
plasmids	NULL
containing	NULL
multimerized	NULL
NF-AT-binding	NULL
sites	NULL
.	NULL

Activity	NULL
of	NULL
the	NULL
reporter	NULL
in	NULL
D5h3	NULL
cells	NULL
was	NULL
significantly	NULL
induced	NULL
by	NULL
treatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
phorbol	NULL
ester	NULL
and	NULL
a	NULL
calcium	NULL
ionophore	NULL
(	NULL
Figure	NULL
3B	NULL
,	NULL
first	NULL
two	NULL
bars	NULL
)	NULL
,	NULL
but	NULL
not	NULL
after	NULL
treatment	NULL
with	NULL
phorbol	NULL
ester	NULL
alone	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
as	NULL
expected	NULL
based	NULL
on	NULL
the	NULL
known	NULL
properties	NULL
of	NULL
NF-AT	NULL
.	NULL

Induced	NULL
activity	NULL
was	NULL
efficiently	NULL
suppressed	NULL
by	NULL
FK506	NULL
;	NULL
however	NULL
,	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
PF	NULL
resulted	NULL
in	NULL
somewhat	NULL
higher	NULL
levels	NULL
of	NULL
transcription	NULL
from	NULL
this	NULL
vector	NULL
(	NULL
Figure	NULL
3B	NULL
,	NULL
last	NULL
two	NULL
bars	NULL
)	NULL
.	NULL

We	NULL
reproducibly	NULL
observed	NULL
increased	NULL
reporter	NULL
activity	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
PF	NULL
.	NULL

Although	NULL
the	NULL
reason	NULL
for	NULL
this	NULL
is	NULL
not	NULL
clear	NULL
at	NULL
present	NULL
,	NULL
one	NULL
possibility	NULL
is	NULL
that	NULL
other	NULL
DNA-binding	NULL
proteins	NULL
that	NULL
are	NULL
suppressed	NULL
by	NULL
PF	NULL
may	NULL
compete	NULL
with	NULL
NF-AT	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
NF-AT	NULL
site	NULL
,	NULL
thus	NULL
decreasing	NULL
the	NULL
effective	NULL
transcription	NULL
activation	NULL
potential	NULL
of	NULL
NF-AT	NULL
in	NULL
such	NULL
assays	NULL
.	NULL

Inhibition	NULL
of	NULL
IL-2	NULL
Gene	NULL
Induction	NULL
by	NULL
PF	NULL
in	NULL
D5h3	NULL
Cells	NULL
Several	NULL
genes	NULL
are	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
T	NULL
cell	NULL
stimulation	NULL
(	NULL
Ullman	NULL
etal	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Among	NULL
these	NULL
,	NULL
the	NULL
genes	NULL
encoding	NULL
IL-2	NULL
and	NULL
IL-2Re	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
subsequent	NULL
T	NULL
cell	NULL
proliferation	NULL
and	NULL
clonal	NULL
expansion	NULL
.	NULL

The	NULL
promoters	NULL
of	NULL
both	NULL
genes	NULL
are	NULL
regulated	NULL
by	NULL
a	NULL
complex	NULL
array	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
some	NULL
of	NULL
which	NULL
are	NULL
induced	NULL
in	NULL
activated	NULL
cells	NULL
and	NULL
others	NULL
of	NULL
which	NULL
are	NULL
constitutively	NULL
expressed	NULL
.	NULL

NF-AT	NULL
was	NULL
first	NULL
identified	NULL
as	NULL
an	NULL
inducible	NULL
factor	NULL
that	NULL
bound	NULL
to	NULL
the	NULL
IL-2	NULL
promoter	NULL
,	NULL
and	NULL
it	NULL
is	NULL
well	NULL
established	NULL
that	NULL
it	NULL
is	NULL
a	NULL
key	NULL
component	NULL
required	NULL
for	NULL
IL-2	NULL
expression	NULL
(	NULL
Emmel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Flanagan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Utz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
both	NULL
the	NULL
IL-2Ra	NULL
(	NULL
Cross	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Leung	NULL
and	NULL
Nabel	NULL
,	NULL
1988	NULL
;	NULL
Lowenthal	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Ruben	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
and	NULL
IL-2	NULL
pro-moters	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
in	NULL
the	NULL
IL-2R	NULL
«	NULL
promoter	NULL
abolishes	NULL
inducible	NULL
promoter	NULL
activity	NULL
,	NULL
indicating	NULL
that	NULL
inducible	NULL
kB-binding	NULL
proteins	NULL
are	NULL
required	NULL
for	NULL
IL-2Ra	NULL
expression	NULL
.	NULL

The	NULL
role	NULL
of	NULL
kB	NULL
proteins	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
IL-2	NULL
is	NULL
less	NULL
clear	NULL
.	NULL

Of	NULL
the	NULL
two	NULL
kB	NULL
elements	NULL
identified	NULL
in	NULL
the	NULL
IL-2	NULL
promoter	NULL
,	NULL
one	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
costimulatory	NULL
response	NULL
mediated	NULL
via	NULL
CD28	NULL
(	NULL
Fraser	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Verweij	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
and	NULL
the	NULL
second	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
promoter	NULL
by	NULL
transactivator	NULL
(	NULL
tax	NULL
)	NULL
of	NULL
type	NULL
1	NULL
human	NULL
T	NULL
lymphotropic	NULL
virus	NULL
(	NULL
HTLV-1	NULL
)	NULL
(	NULL
Ruben	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

Neither	NULL
site	NULL
had	NULL
been	NULL
considered	NULL
crucial	NULL
for	NULL
IL-2	NULL
induction	NULL
by	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
;	NULL
however	NULL
,	NULL
a	NULL
recent	NULL
study	NULL
found	NULL
that	NULL
the	NULL
distal	NULL
NF-	NULL
«	NULL
B-binding	NULL
site	NULL
was	NULL
important	NULL
for	NULL
IL-2	NULL
induction	NULL
by	NULL
phytohemagglutinin	NULL
(	NULL
PHA	NULL
)	NULL
plus	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
(	NULL
PMA	NULL
)	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
(	NULL
Hughes	NULL
and	NULL
Pober	NULL
,	NULL
1996	NULL
)	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
importance	NULL
of	NULL
IL-2	NULL
and	NULL
IL-2Ra	NULL
«	NULL
genes	NULL
in	NULL
T	NULL
cell	NULL
Immunity	NULL
168	NULL
Anti-CD3	NULL
-	NULL
Anti-CD3+PF	NULL
£	NULL
G	NULL
2	NULL
V	NULL
O	NULL
F	NULL
&	NULL
&	NULL
S	NULL
Antiserum	NULL
&	NULL
£	NULL
«	NULL
¢	NULL
£	NULL
&	NULL
&	NULL
€	NULL
J	NULL
J	NULL
C	NULL
&	NULL
&	NULL
nub	NULL
j	NULL
supershifts	NULL
10	NULL
203	NULL
4	NULL
5	NULL
6	NULL
0°	NULL
Untreated	NULL
CAT	NULL
concentration	NULL
(	NULL
ng/m	NULL
!	NULL
)	NULL

Pil	NULL
Figure	NULL
3	NULL
.	NULL

Characterization	NULL
of	NULL
Inducible	NULL
NF-AT	NULL
Activity	NULL
in	NULL
Cells	NULL
Treated	NULL
with	NULL
PF	NULL
{	NULL
A	NULL
)	NULL
Electrophoretic	NULL
mobility	NULL
supershift	NULL
assays	NULL
.	NULL

Standard	NULL
in	NULL
vitro	NULL
binding	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
using	NULL
the	NULL
NF-AT	NULL
probe	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
followed	NULL
by	NULL
addition	NULL
of	NULL
normal	NULL
rabbit	NULL
serum	NULL
(	NULL
NRS	NULL
)	NULL
,	NULL
anti-NF-AT	NULL
antiserum	NULL
(	NULL
NF-AT	NULL
,	NULL
}	NULL
,	NULL
and	NULL
anti-NF-AT	NULL
;	NULL
monoclonal	NULL
antibody	NULL
7A6	NULL
(	NULL
NF-AT	NULL
,	NULL
)	NULL
to	NULL
the	NULL
reactions	NULL
and	NULL
further	NULL
incubation	NULL
for	NULL
1	NULL
hr	NULL
on	NULL
ice	NULL
.	NULL

Subsequent	NULL
analysis	NULL
by	NULL
nondenaturing	NULL
electrophoresis	NULL
was	NULL
as	NULL
usual	NULL
for	NULL
EMSA	NULL
.	NULL

Nuclear	NULL
extracts	NULL
analyzed	NULL
were	NULL
obtained	NULL
from	NULL
D5h3	NULL
cells	NULL
activated	NULL
by	NULL
plate-bound	NULL
anti-CD3	NULL
antibodies	NULL
for	NULL
4	NULL
hr	NULL
in	NULL
the	NULL
absence	NULL
{	NULL
lanes	NULL
1-3	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
PF	NULL
(	NULL
lanes	NULL
4-6	NULL
)	NULL
.	NULL

The	NULL
two	NULL
major	NULL
bands	NULL
seen	NULL
PIPE	NULL
in	NULL
lane	NULL
1	NULL
represent	NULL
the	NULL
complete	NULL
NF-AT	NULL
complex	NULL
(	NULL
including	NULL
AP-1	NULL
;	NULL
upper	NULL
band	NULL
)	NULL
and	NULL
the	NULL
,	NULL
,	NULL
;	NULL
complex	NULL
alone	NULL
(	NULL
lower	NULL
band	NULL
)	NULL
.	NULL

Positions	NULL
of	NULL
supershifted	NULL
bands	NULL
induced	NULL
by	NULL
anti-NF-AT	NULL
,	NULL
antibodies	NULL
are	NULL
indicated	NULL
to	NULL
the	NULL
right	NULL
of	NULL
the	NULL
figure	NULL
;	NULL
the	NULL
upper	NULL
supershift	NULL
band	NULL
presumably	NULL
represents	NULL
the	NULL
complete	NULL
NF-AT	NULL
complex	NULL
,	NULL
and	NULL
the	NULL
lower	NULL
supershift	NULL
band	NULL
presumably	NULL
represents	NULL
the	NULL
partial	NULL
NF-AT	NULL
,	NULL
,	NULL
,	NULL
complex	NULL
.	NULL

{	NULL
B	NULL
)	NULL
Transcription	NULL
activation	NULL
properties	NULL
of	NULL
NF-AT	NULL
.	NULL

A	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
containing	NULL
multimerized	NULL
NF-AT-binding	NULL
sites	NULL
upstream	NULL
of	NULL
a	NULL
truncated	NULL
c-fos	NULL
gene	NULL
promoter	NULL
(	NULL
Venkataraman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
was	NULL
transiently	NULL
transfected	NULL
into	NULL
D5h3	NULL
cells	NULL
.	NULL

After	NULL
24	NULL
hr	NULL
,	NULL
cells	NULL
were	NULL
left	NULL
untreated	NULL
or	NULL
were	NULL
treated	NULL
with	NULL
phorbol	NULL
ester	NULL
plus	NULL
ionomycin	NULL
alone	NULL
(	NULL
P+	NULL
!	NULL
)	NULL

or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PF	NULL
{	NULL
labeled	NULL
P+I+F	NULL
)	NULL
or	NULL
FK506	NULL
(	NULL
labeled	NULL
P+I+FK	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
4	NULL
hr	NULL
after	NULL
treatment	NULL
,	NULL
and	NULL
CAT	NULL
enzyme	NULL
levels	NULL
in	NULL
equal	NULL
amounts	NULL
of	NULL
whole-cell	NULL
extracts	NULL
were	NULL
determined	NULL
by	NULL
ELISA	NULL
.	NULL

Results	NULL
shown	NULL
are	NULL
derived	NULL
from	NULL
two	NULL
sets	NULL
of	NULL
transfections	NULL
carried	NULL
out	NULL
in	NULL
duplicate	NULL
.	NULL

activation	NULL
,	NULL
and	NULL
the	NULL
possible	NULL
involvement	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
for	NULL
expression	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
PF	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
IL-2	NULL
and	NULL
IL-2Re	NULL
mRNA	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
RNA	NULL
isolated	NULL
from	NULL
DS5h3	NULL
cells	NULL
showed	NULL
that	NULL
both	NULL
IL-2Re	NULL
and	NULL
IL-2	NULL
mRNAs	NULL
were	NULL
induced	NULL
with	NULL
anti-CD3	NULL
treatment	NULL
(	NULL
Figures	NULL
4A	NULL
and	NULL
4B	NULL
)	NULL
.	NULL

When	NULL
the	NULL
cells	NULL
were	NULL
activated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PF	NULL
,	NULL
we	NULL
observed	NULL
a	NULL
partial	NULL
suppression	NULL
of	NULL
IL-2R	NULL
«	NULL
mRNA	NULL
levels	NULL
(	NULL
Figure	NULL
4A	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
a	NULL
small	NULL
difference	NULL
in	NULL
the	NULL
RNA	NULL
loading	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
reprobing	NULL
the	NULL
filters	NULL
with	NULL
a	NULL
glyceraldehyde	NULL
phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
probe	NULL
A	NULL
B	NULL
L	NULL
L	NULL
es	NULL
es	NULL
C	NULL
C	NULL
$	NULL
A	NULL
A	NULL
$	NULL
A	NULL
A	NULL
$	NULL
9	NULL
9	NULL
$	NULL
Q9	NULL
9	NULL
2	NULL
EE	NULL
Bog	NULL
#	NULL
g	NULL
C	NULL
E	NULL
c	NULL
C	NULL
C	NULL
3	NULL
<	NULL
<	NULL
3	NULL
<	NULL
<	NULL
wee	NULL
IL-2Ra	NULL
.	NULL

<	NULL
-	NULL
IL-2	NULL
1	NULL
2	NULL
3	NULL
1°	NULL
203	NULL
C	NULL
Untreated	NULL
Anti-CD3	NULL
Anti-CD3+PF	NULL
*	NULL
o	NULL
>	NULL
As	NULL
=	NULL
I	NULL
aa	NULL
No	NULL
Figure	NULL
4	NULL
.	NULL

Analysis	NULL
of	NULL
Inducible	NULL
Gene	NULL
Expression	NULL
in	NULL
D5h3	NULL
Cells	NULL
Total	NULL
RNA	NULL
isolated	NULL
from	NULL
cells	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
treated	NULL
as	NULL
indicated	NULL
was	NULL
fractionated	NULL
through	NULL
formaldehyde-containing	NULL
agarose	NULL
gels	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
filters	NULL
,	NULL
and	NULL
hybridized	NULL
to	NULL
radioactive	NULL
probes	NULL
derived	NULL
from	NULL
IL-2Ra	NULL
(	NULL
A	NULL
)	NULL
and	NULL
IL-2	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
glyceraldehyde	NULL
phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
(	NULL
C	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
for	NULL
RNA	NULL
loading	NULL
.	NULL

(	NULL
Figure	NULL
4C	NULL
)	NULL
,	NULL
may	NULL
account	NULL
for	NULL
most	NULL
of	NULL
the	NULL
difference	NULL
in	NULL
IL-2Ra	NULL
mRNA	NULL
expression	NULL
.	NULL

Thus	NULL
,	NULL
IL-2R	NULL
«	NULL
mRNA	NULL
expression	NULL
was	NULL
not	NULL
significantly	NULL
affected	NULL
by	NULL
PF	NULL
,	NULL
despite	NULL
the	NULL
reduction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

A	NULL
possible	NULL
explanation	NULL
may	NULL
be	NULL
that	NULL
the	NULL
lower	NULL
levels	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
are	NULL
sufficient	NULL
for	NULL
IL-2Ra	NULL
«	NULL
induction	NULL
or	NULL
,	NULL
alternatively	NULL
,	NULL
that	NULL
a	NULL
Rel	NULL
protein	NULL
with	NULL
low	NULL
DNA	NULL
binding	NULL
affinity	NULL
(	NULL
such	NULL
as	NULL
a	NULL
p65	NULL
homodimer	NULL
)	NULL
may	NULL
be	NULL
the	NULL
functional	NULL
IL-2Ra	NULL
«	NULL
promoter	NULL
factor	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IL-2	NULL
mRNA	NULL
induction	NULL
was	NULL
completely	NULL
suppressed	NULL
by	NULL
PF	NULL
(	NULL
Figure	NULL
4B	NULL
)	NULL
,	NULL
despite	NULL
the	NULL
negligible	NULL
effect	NULL
of	NULL
this	NULL
drug	NULL
on	NULL
NF-AT	NULL
induction	NULL
and	NULL
transcription	NULL
activation	NULL
by	NULL
NF-AT	NULL
.	NULL

These	NULL
observations	NULL
indicate	NULL
that	NULL
NF-AT	NULL
,	NULL
and	NULL
by	NULL
extrapolation	NULL
AP-1	NULL
proteins	NULL
,	NULL
are	NULL
not	NULL
sufficient	NULL
for	NULL
IL-2	NULL
expression	NULL
and	NULL
that	NULL
other	NULL
inducible	NULL
factors	NULL
are	NULL
required	NULL
to	NULL
synergize	NULL
with	NULL
NF-AT	NULL
to	NULL
activate	NULL
this	NULL
promoter	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
observed	NULL
inhibition	NULL
of	NULL
Rel	NULL
proteins	NULL
by	NULL
PF	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
may	NULL
be	NULL
the	NULL
missing	NULL
components	NULL
necessary	NULL
for	NULL
IL-2	NULL
gene	NULL
induction	NULL
.	NULL

PF	NULL
Inhibits	NULL
c-Rel	NULL
and	NULL
IL-2	NULL
Induction	NULL
in	NULL
Splenic	NULL
T	NULL
Cells	NULL
To	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
observations	NULL
described	NULL
above	NULL
were	NULL
due	NULL
to	NULL
the	NULL
transformed	NULL
nature	NULL
of	NULL
D5h3	NULL
cells	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
PF	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
primary	NULL
,	NULL
untransformed	NULL
T	NULL
cells	NULL
.	NULL

Concanavalin	NULL
A	NULL
(	NULL
ConA	NULL
)	NULL
blasts	NULL
of	NULL
splenic	NULL
cells	NULL
were	NULL
activated	NULL
by	NULL
anti-CD3	NULL
cross-linking	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
PF	NULL
and	NULL
FK506	NULL
and	NULL
assayed	NULL
by	NULL
EMSA	NULL
,	NULL
immunoblotting	NULL
and	NULL
Northern	NULL
blots	NULL
.	NULL

NF-kB	NULL
DNA	NULL
binding	NULL
was	NULL
strongly	NULL
induced	NULL
by	NULL
anti-CD3	NULL
stimulation	NULL
(	NULL
Figure	NULL
5A	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

The	NULL
induced	NULL
nucleoprotein	NULL
complex	NULL
contained	NULL
both	NULL
p65	NULL
and	NULL
c-Rel	NULL
(	NULL
probably	NULL
in	NULL
p50/p65	NULL
and	NULL
p50/c-Rel	NULL
heter-odimeric	NULL
forms	NULL
)	NULL
,	NULL
as	NULL
ascertained	NULL
by	NULL
supershift	NULL
analysis	NULL
with	NULL
anti-p65	NULL
as	NULL
well	NULL
as	NULL
anti-c-Rel	NULL
antibody	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
with	NULL
the	NULL
observation	NULL
in	NULL
D5h3	NULL
cells	NULL
,	NULL
NF-kB	NULL
binding	NULL
was	NULL
not	NULL
inhibited	NULL
when	NULL
the	NULL
cells	NULL
were	NULL
activated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PF	NULL
(	NULL
Figure	NULL
5A	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
;	NULL
however	NULL
,	NULL
inclusion	NULL
of	NULL
FK506	NULL
reduced	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
significantly	NULL
(	NULL
Figure	NULL
5A	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Effects	NULL
of	NULL
the	NULL
drugs	NULL
on	NULL
NF-AT	NULL
induction	NULL
closely	NULL
paralleled	NULL
the	NULL
pattern	NULL
seen	NULL
in	NULL
D5h3	NULL
Regulation	NULL
of	NULL
Rel	NULL
Proteins	NULL
in	NULL
Lymphocytes	NULL
A	NULL
B	NULL
©	NULL
&	NULL
D	NULL
a	NULL
$	NULL
“	NULL
(	NULL
0mm	NULL
C	NULL
€	NULL
o	NULL
A	NULL
o	NULL
8	NULL
§	NULL
$	NULL
g	NULL
9	NULL
9	NULL
§	NULL
9	NULL
€	NULL
E	NULL
#	NULL
T	NULL
Eo	NULL
z	NULL
20	NULL
c	NULL
C	NULL
C	NULL
2	NULL
C	NULL
3	NULL
<	NULL
<	NULL
<	NULL
S	NULL
<	NULL
``	NULL
I1	NULL
4	NULL
1	NULL
203	NULL
4	NULL
©	NULL
1	NULL
2	NULL
3	NULL
4	NULL
&	NULL
D	NULL
u.	NULL
P4	NULL
e	NULL
C	NULL
c	NULL
g	NULL
-	NULL
Bo	NULL
B	NULL
8	NULL
8	NULL
9	NULL
9	NULL
9	NULL
E	NULL
T	NULL
T	NULL
E	NULL
has	NULL
<	NULL
<	NULL
I	NULL
N	NULL
Cc	NULL
N	NULL
c	NULL
Nn	NULL
c	NULL
noc	NULL
101	NULL
-	NULL
@	NULL
-	NULL
|	NULL
-	NULL
go	NULL
«	NULL
-_	NULL
»	NULL
~	NULL
o	NULL
--	NULL
=	NULL
<	NULL
4	NULL
c-Rel	NULL
51	NULL
35	NULL
cells	NULL
.	NULL

Specifically	NULL
,	NULL
NF-AT	NULL
induction	NULL
(	NULL
Figure	NULL
5B	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
was	NULL
not	NULL
blocked	NULL
by	NULL
PF	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
but	NULL
was	NULL
totally	NULL
abrogated	NULL
by	NULL
FK506	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
PF	NULL
does	NULL
not	NULL
suppress	NULL
either	NULL
NF-kB	NULL
or	NULL
NF-AT	NULL
induction	NULL
in	NULL
primary	NULL
T	NULL
cells	NULL
,	NULL
whereas	NULL
FK506	NULL
suppresses	NULL
both	NULL
inducible	NULL
factors	NULL
.	NULL

Because	NULL
most	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
observed	NULL
involves	NULL
the	NULL
p50/p65	NULL
heterodimer	NULL
,	NULL
we	NULL
surmise	NULL
that	NULL
the	NULL
lack	NULL
of	NULL
an	NULL
effect	NULL
of	NULL
PF	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
measured	NULL
by	NULL
EMSA	NULL
indicates	NULL
that	NULL
p50/p65	NULL
heterodimer	NULL
induction	NULL
is	NULL
unaffected	NULL
by	NULL
this	NULL
drug	NULL
.	NULL

However	NULL
,	NULL
as	NULL
shown	NULL
below	NULL
,	NULL
c-Rel	NULL
induction	NULL
by	NULL
anti-CD3	NULL
was	NULL
inhibited	NULL
by	NULL
PF	NULL
.	NULL

We	NULL
assayed	NULL
specific	NULL
Rel	NULL
family	NULL
members	NULL
by	NULL
immunoblotting	NULL
.	NULL

Nuclear	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
prepared	NULL
from	NULL
cells	NULL
treated	NULL
in	NULL
various	NULL
ways	NULL
were	NULL
fractionated	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
,	NULL
and	NULL
probed	NULL
with	NULL
anti-c-Rel	NULL
or	NULL
anti-Rel	NULL
B	NULL
antisera	NULL
.	NULL

Because	NULL
equal	NULL
amounts	NULL
of	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
used	NULL
,	NULL
the	NULL
relative	NULL
distribution	NULL
of	NULL
the	NULL
proteins	NULL
in	NULL
the	NULL
nucleus	NULL
is	NULL
overestimated	NULL
3-	NULL
to	NULL
4-fold	NULL
.	NULL

In	NULL
untreated	NULL
T	NULL
cells	NULL
,	NULL
c-Rel	NULL
protein	NULL
was	NULL
mostly	NULL
restricted	NULL
to	NULL
the	NULL
cytoplasmic	NULL
fraction	NULL
(	NULL
Figure	NULL
5C	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

Anti-CD3	NULL
treatment	NULL
resulted	NULL
in	NULL
increased	NULL
c-Rel	NULL
expression	NULL
in	NULL
both	NULL
the	NULL
nucleus	NULL
and	NULL
the	NULL
cytoplasm	NULL
(	NULL
Figure	NULL
5C	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
and	NULL
the	NULL
induction	NULL
was	NULL
blocked	NULL
by	NULL
both	NULL
PF	NULL
and	NULL
FK506	NULL
(	NULL
lanes	NULL
5-8	NULL
)	NULL
.	NULL

Rel	NULL
B	NULL
expression	NULL
was	NULL
not	NULL
significantly	NULL
affected	NULL
by	NULL
PF	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
as	NULL
seen	NULL
above	NULL
in	NULL
D5h3	NULL
cells	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
induction	NULL
of	NULL
certain	NULL
Rel	NULL
proteins	NULL
such	NULL
as	NULL
c-Rel	NULL
,	NULL
but	NULL
not	NULL
other	NULL
Rel	NULL
proteins	NULL
such	NULL
as	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
p50/p65	NULL
)	NULL
or	NULL
Rel	NULL
B	NULL
,	NULL
is	NULL
blocked	NULL
by	NULL
PF	NULL
in	NULL
untransformed	NULL
T	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
both	NULL
PF	NULL
and	NULL
FK506	NULL
block	NULL
c-Rel	NULL
induction	NULL
,	NULL
but	NULL
in	NULL
addition	NULL
FK506	NULL
blocks	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
NF-AT	NULL
induction	NULL
as	NULL
well	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
effects	NULL
of	NULL
PF	NULL
on	NULL
inducible	NULL
T	NULL
cell	NULL
genes	NULL
,	NULL
Anti-CD3+PF	NULL
Ae	NULL
Figure	NULL
5	NULL
.	NULL

Comparison	NULL
of	NULL
Nuclear	NULL
Factor	NULL
Induction	NULL
in	NULL
Splenic	NULL
T	NULL
Cells	NULL
Activated	NULL
in	NULL
the	NULL
Presence	NULL
of	NULL
PF	NULL
or	NULL
FK506	NULL
{	NULL
A	NULL
)	NULL
Analysis	NULL
of	NULL
NF-kB	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
splenic	NULL
T	NULL
cell	NULL
ConA	NULL
blasts	NULL
treated	NULL
as	NULL
indicated	NULL
above	NULL
the	NULL
lanes	NULL
.	NULL

EMSA	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
H2K	NULL
probe	NULL
and	NULL
3	NULL
g	NULL
of	NULL
nuclear	NULL
extracts	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
the	NULL
position	NULL
of	NULL
the	NULL
major	NULL
inducible	NULL
NF-kB	NULL
nucleoprotein	NULL
complex	NULL
.	NULL

The	NULL
lower	NULL
,	NULL
unlabeled	NULL
band	NULL
contains	NULL
p50/p50	NULL
homodimers	NULL
.	NULL

{	NULL
B	NULL
)	NULL
Analysis	NULL
of	NULL
NF-AT	NULL
induction	NULL
in	NULL
the	NULL
same	NULL
extracts	NULL
.	NULL

Positions	NULL
of	NULL
the	NULL
AP-1-containing	NULL
complete	NULL
NF-AT	NULL
complex	NULL
and	NULL
the	NULL
partial	NULL
,	NULL
preexisting	NULL
NF-AT	NULL
complex	NULL
are	NULL
indicated	NULL
by	NULL
the	NULL
upper	NULL
and	NULL
lower	NULL
arrows	NULL
,	NULL
respectively	NULL
.	NULL

{	NULL
C	NULL
)	NULL
Effect	NULL
of	NULL
PF	NULL
and	NULL
FK506	NULL
on	NULL
c-Rel	NULL
induction	NULL
in	NULL
splenic	NULL
T	NULL
cells	NULL
.	NULL

Nuclear	NULL
(	NULL
N	NULL
)	NULL
and	NULL
cytoplasmic	NULL
{	NULL
C	NULL
)	NULL
extracts	NULL
(	NULL
6	NULL
mg	NULL
)	NULL
from	NULL
cells	NULL
activated	NULL
as	NULL
indicated	NULL
were	NULL
fractionated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
,	NULL
which	NULL
were	NULL
probed	NULL
with	NULL
anti-c-Rel	NULL
antiserum	NULL
.	NULL

Position	NULL
of	NULL
the	NULL
c-Rel	NULL
protein	NULL
is	NULL
shown	NULL
by	NULL
the	NULL
arrow	NULL
.	NULL

Anti-CD3+FK506	NULL
<	NULL
-	NULL
NF-AT	NULL
<	NULL
<	NULL
4-	NULL
NF-ATp	NULL
we	NULL
assayed	NULL
IL-2	NULL
and	NULL
IL-2R	NULL
«	NULL
e	NULL
mRNA	NULL
expression	NULL
by	NULL
Northern	NULL
blotting	NULL
.	NULL

Both	NULL
genes	NULL
were	NULL
strongly	NULL
induced	NULL
by	NULL
anti-CD3	NULL
treatment	NULL
(	NULL
Figures	NULL
6A	NULL
and	NULL
6B	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
and	NULL
neither	NULL
drug	NULL
affected	NULL
IL-2Ra	NULL
«	NULL
expression	NULL
.	NULL

Previously	NULL
,	NULL
it	NULL
has	NULL
been	NULL
noted	NULL
that	NULL
IL-2Ra	NULL
«	NULL
expression	NULL
decreased	NULL
approximately	NULL
2-fold	NULL
in	NULL
peripheral	NULL
human	NULL
mononuclear	NULL
cells	NULL
activated	NULL
for	NULL
3	NULL
days	NULL
with	NULL
PHA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PF	NULL
.	NULL

This	NULL
small	NULL
quantitative	NULL
difference	NULL
from	NULL
our	NULL
results	NULL
could	NULL
be	NULL
due	NULL
to	NULL
the	NULL
extended	NULL
period	NULL
of	NULL
stimulation	NULL
used	NULL
in	NULL
that	NULL
study	NULL
,	NULL
the	NULL
cell	NULL
type	NULL
and	NULL
activation	NULL
agent	NULL
used	NULL
,	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
these	NULL
parameters	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
PF	NULL
does	NULL
not	NULL
significantly	NULL
affect	NULL
IL-2R	NULL
«	NULL
mRNA	NULL
induction	NULL
.	NULL

However	NULL
,	NULL
IL-2	NULL
expression	NULL
was	NULL
inhibited	NULL
by	NULL
both	NULL
PF	NULL
and	NULL
FK506	NULL
(	NULL
Figure	NULL
6A	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
are	NULL
similar	NULL
to	NULL
those	NULL
in	NULL
D5h3	NULL
cells	NULL
and	NULL
show	NULL
that	NULL
the	NULL
IL-2	NULL
gene	NULL
is	NULL
suppressed	NULL
by	NULL
PF	NULL
,	NULL
even	NULL
though	NULL
this	NULL
drug	NULL
does	NULL
not	NULL
affect	NULL
either	NULL
NF-	NULL
«	NULL
B	NULL
or	NULL
NF-AT	NULL
induction	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
suppression	NULL
of	NULL
c-Rel	NULL
induction	NULL
by	NULL
PF	NULL
and	NULL
the	NULL
possible	NULL
involvement	NULL
of	NULL
a	NULL
kB	NULL
element	NULL
in	NULL
IL-2	NULL
gene	NULL
induction	NULL
,	NULL
we	NULL
suggest	NULL
that	NULL
c-Rel	NULL
may	NULL
be	NULL
a	NULL
critical	NULL
component	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

c-Rel	NULL
and	NULL
NF-AT	NULL
,	NULL
,	NULL
Activate	NULL
the	NULL
IL-2	NULL
Promoter	NULL
To	NULL
test	NULL
whether	NULL
the	NULL
c-Rel	NULL
gene	NULL
product	NULL
could	NULL
activate	NULL
the	NULL
IL-2	NULL
gene	NULL
promoter	NULL
,	NULL
we	NULL
carried	NULL
out	NULL
the	NULL
following	NULL
transfection	NULL
experiments	NULL
.	NULL

A	NULL
reporter	NULL
plasmid	NULL
containing	NULL
the	NULL
600	NULL
bp	NULL
complete	NULL
IL-2	NULL
promoter	NULL
fragment	NULL
(	NULL
Hughes	NULL
and	NULL
Pober	NULL
,	NULL
1996	NULL
)	NULL
was	NULL
cotransfected	NULL
along	NULL
with	NULL
expression	NULL
vectors	NULL
for	NULL
c-Rel	NULL
(	NULL
Pierce	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
and	NULL
NF-AT	NULL
;	NULL
(	NULL
Northrop	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
into	NULL
293	NULL
(	NULL
nonlymphoid	NULL
)	NULL
cells	NULL
,	NULL
and	NULL
promoter	NULL
activity	NULL
was	NULL
measured	NULL
using	NULL
a	NULL
luciferase	NULL
assay	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
IL-2	NULL
reporter	NULL
was	NULL
inactive	NULL
in	NULL
Immunity	NULL
170	NULL
A	NULL
B	NULL
w	NULL
w	NULL
&	NULL
&	NULL
in	NULL
5	NULL
wo	NULL
L	NULL
MC	NULL
15	NULL
5	NULL
$	NULL
I	NULL
2	NULL
®	NULL
o	NULL
I	NULL
2	NULL
a	NULL
a	NULL
-	NULL
o	NULL
o	NULL
o	NULL
a	NULL
o	NULL
o	NULL
o	NULL
8000	NULL
8	NULL
o	NULL
0	NULL
o	NULL
©	NULL
ob	NULL
Ao	NULL
L	NULL
@	NULL
b	NULL
L	NULL
L	NULL
Bo	NULL
wou	NULL
&	NULL
Bo	NULL
ou	NULL
&	NULL
g	NULL
C	NULL
C	NULL
C	NULL
g	NULL
C	NULL
C	NULL
C	NULL
o	NULL
<	NULL
4	NULL
4	NULL
3	NULL
<	NULL
<	NULL
4	NULL
<	NULL
.	NULL

<	NULL
-	NULL
IL-2	NULL
ww	NULL
oan	NULL
wn	NULL
-	NULL
<	NULL
-	NULL
1L-2Rc	NULL
:	NULL
102	NULL
3	NULL
4	NULL
102	NULL
3	NULL
4	NULL
C	NULL
w	NULL
o	NULL
G	NULL
wo	NULL
#	NULL
$	NULL
I	NULL
9	NULL
o	NULL
o	NULL
2	NULL
o	NULL
o	NULL
o	NULL
8	NULL
9	NULL
9	NULL
Q9	NULL
Eo	NULL
®	NULL
s	NULL
c	NULL
C	NULL
C	NULL
C	NULL
o	NULL
4G	NULL
4	NULL
4	NULL
ae	NULL
as	NULL
4s	NULL
<	NULL
-	NULL
GAPDH	NULL
102	NULL
3	NULL
4	NULL
Figure	NULL
6	NULL
.	NULL

Expression	NULL
of	NULL
Inducible	NULL
Genes	NULL
in	NULL
Splenic	NULL
T	NULL
Cells	NULL
Total	NULL
RNA	NULL
isolated	NULL
from	NULL
the	NULL
cells	NULL
(	NULL
10	NULL
pg	NULL
)	NULL
treated	NULL
as	NULL
indicated	NULL
was	NULL
fractionated	NULL
through	NULL
formaldehyde-containing	NULL
agarose	NULL
gels	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
filters	NULL
,	NULL
which	NULL
were	NULL
hybridized	NULL
to	NULL
radioactive	NULL
probes	NULL
derived	NULL
from	NULL
IL-2	NULL
(	NULL
A	NULL
)	NULL
and	NULL
IL-2R	NULL
«	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Equivalent	NULL
RNA	NULL
loading	NULL
was	NULL
determined	NULL
by	NULL
assaying	NULL
GAPDH	NULL
expression	NULL
(	NULL
C	NULL
)	NULL
.	NULL

these	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
cotransfected	NULL
transactivators	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
.	NULL

Neither	NULL
the	NULL
expression	NULL
of	NULL
c-Rel	NULL
nor	NULL
NF-AT	NULL
alone	NULL
activated	NULL
the	NULL
IL-2	NULL
promoter	NULL
significantly	NULL
under	NULL
these	NULL
experimental	NULL
conditions	NULL
(	NULL
Figure	NULL
7	NULL
,	NULL
first	NULL
three	NULL
bars	NULL
)	NULL
.	NULL

However	NULL
,	NULL
coexpression	NULL
of	NULL
both	NULL
c-Rel	NULL
and	NULL
NF-AT	NULL
;	NULL
together	NULL
resulted	NULL
in	NULL
synergistic	NULL
transactivation	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
Figure	NULL
7	NULL
,	NULL
fourth	NULL
bar	NULL
)	NULL
,	NULL
strengthening	NULL
our	NULL
hypothesis	NULL
that	NULL
c-Rel	NULL
is	NULL
a	NULL
functional	NULL
IL-2	NULL
promoter	NULL
factor	NULL
.	NULL

While	NULL
carrying	NULL
out	NULL
these	NULL
studies	NULL
,	NULL
we	NULL
noticed	NULL
that	NULL
the	NULL
IL-2	NULL
promoter	NULL
was	NULL
also	NULL
transactivated	NULL
to	NULL
low	NULL
levels	NULL
with	NULL
either	NULL
c-Rel	NULL
or	NULL
NF-AT	NULL
;	NULL
when	NULL
these	NULL
factors	NULL
were	NULL
expressed	NULL
individually	NULL
at	NULL
higher	NULL
levels	NULL
,	NULL
and	NULL
coexpression	NULL
resulted	NULL
in	NULL
transcriptional	NULL
synergy	NULL
similar	NULL
to	NULL
the	NULL
results	NULL
shown	NULL
in	NULL
Figure	NULL
7	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

An	NULL
additional	NULL
point	NULL
needs	NULL
to	NULL
be	NULL
clarified	NULL
.	NULL

Because	NULL
it	NULL
was	NULL
recently	NULL
shown	NULL
that	NULL
both	NULL
NF-AT	NULL
,	NULL
and	NULL
NF-AT	NULL
,	NULL
activated	NULL
a	NULL
cotransfected	NULL
IL-2	NULL
promoter	NULL
to	NULL
equivalent	NULL
levels	NULL
(	NULL
Timmerman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
,	NULL
we	NULL
have	NULL
not	NULL
repeated	NULL
the	NULL
studies	NULL
described	NULL
here	NULL
with	NULL
NF-AT	NULL
,	NULL
.	NULL

Our	NULL
observations	NULL
provide	NULL
direct	NULL
evidence	NULL
for	NULL
functional	NULL
cooperation	NULL
between	NULL
NF-AT	NULL
and	NULL
Rel	NULL
proteins	NULL
,	NULL
and	NULL
implicate	NULL
both	NULL
factors	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
IL-2	NULL
gene	NULL
expression	NULL
.	NULL

PF	NULL
Does	NULL
Not	NULL
Inhibit	NULL
c-Rel	NULL
Induction	NULL
in	NULL
B	NULL
Cells	NULL
Activated	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
share	NULL
many	NULL
common	NULL
features	NULL
.	NULL

For	NULL
example	NULL
,	NULL
both	NULL
cell	NULL
types	NULL
require	NULL
the	NULL
dual	NULL
signal	NULL
provided	NULL
by	NULL
phorbol	NULL
ester	NULL
and	NULL
ionomycin	NULL
to	NULL
proliferate	NULL
;	NULL
both	NULL
cell	NULL
types	NULL
induce	NULL
NF-AT	NULL
and	NULL
c-Rel	NULL
proteins	NULL
only	NULL
in	NULL
response	NULL
to	NULL
this	NULL
``	NULL
complete	NULL
``	NULL
proliferative	NULL
signal	NULL
(	NULL
Venkataraman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
,	NULL
1995	NULL
)	NULL
;	NULL
and	NULL
immunosuppressive	NULL
drugs	NULL
such	NULL
as	NULL
cyclosporin	NULL
A	NULL
and	NULL
FK506	NULL
have	NULL
similar	NULL
107	NULL
8	NULL
[	NULL
3	NULL
2	NULL
B	NULL
PS	NULL
64	NULL
®	NULL
y	NULL
£	NULL
2	NULL
®	NULL
&	NULL
-	NULL
24	NULL
0	NULL
-	NULL
NF-ATe	NULL
c-Rel	NULL
_	NULL
NF-ATc+c-Rel	NULL
Figure	NULL
7	NULL
.	NULL

Transactivation	NULL
of	NULL
IL-2	NULL
Promoter	NULL
by	NULL
c-Rel	NULL
and	NULL
NF-AT	NULL
A	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
containing	NULL
the	NULL
wild-type	NULL
human	NULL
IL-2	NULL
gene	NULL
promoter	NULL
was	NULL
cotransfected	NULL
into	NULL
293	NULL
human	NULL
embryonic	NULL
kidney	NULL
cells	NULL
together	NULL
with	NULL
expression	NULL
vectors	NULL
for	NULL
c-Rel	NULL
and	NULL
NF-AT	NULL
,	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Cell	NULL
extracts	NULL
prepared	NULL
40	NULL
hr	NULL
after	NULL
transfection	NULL
were	NULL
assayed	NULL
for	NULL
luciferase	NULL
expression	NULL
.	NULL

Activity	NULL
of	NULL
the	NULL
reporter	NULL
plasmid	NULL
is	NULL
shown	NULL
normalized	NULL
to	NULL
that	NULL
seen	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
cotransfected	NULL
transactivators	NULL
(	NULL
first	NULL
bar	NULL
)	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
are	NULL
derived	NULL
from	NULL
two	NULL
sets	NULL
of	NULL
transfections	NULL
carried	NULL
out	NULL
in	NULL
duplicate	NULL
.	NULL

effects	NULL
on	NULL
both	NULL
cell	NULL
types	NULL
.	NULL

We	NULL
therefore	NULL
investigated	NULL
whether	NULL
PF	NULL
would	NULL
have	NULL
the	NULL
same	NULL
effect	NULL
on	NULL
B	NULL
cells	NULL
as	NULL
we	NULL
observed	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Bal	NULL
17	NULL
B	NULL
lymphoma	NULL
cells	NULL
were	NULL
activated	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
PF	NULL
and	NULL
assayed	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
expression	NULL
by	NULL
EMSA	NULL
and	NULL
immunoblotting	NULL
.	NULL

These	NULL
cells	NULL
contain	NULL
constitutive	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
that	NULL
is	NULL
detectable	NULL
by	NULL
EMSA	NULL
in	NULL
uninduced	NULL
cells	NULL
(	NULL
Figure	NULL
8A	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Increased	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
evident	NULL
after	NULL
stimulation	NULL
with	NULL
phorbol	NULL
ester	NULL
and	NULL
ionomycin	NULL
(	NULL
Figure	NULL
8A	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
which	NULL
was	NULL
not	NULL
suppressed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
PF	NULL
or	NULL
FK506	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

A	NULL
lack	NULL
of	NULL
sensitivity	NULL
to	NULL
PF	NULL
is	NULL
reminiscent	NULL
of	NULL
our	NULL
observation	NULL
in	NULL
primary	NULL
T	NULL
cells	NULL
;	NULL
however	NULL
,	NULL
insensitivity	NULL
to	NULL
FK506	NULL
is	NULL
clearly	NULL
different	NULL
from	NULL
the	NULL
effects	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Surprisingly	NULL
,	NULL
unlike	NULL
T	NULL
cells	NULL
,	NULL
PF	NULL
did	NULL
not	NULL
affect	NULL
c-Rel	NULL
induction	NULL
in	NULL
Bal	NULL
17	NULL
B	NULL
cells	NULL
(	NULL
Figure	NULL
8B	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
in	NULL
several	NULL
independent	NULL
experiments	NULL
we	NULL
noted	NULL
that	NULL
the	NULL
total	NULL
cellular	NULL
levels	NULL
of	NULL
c-Rel	NULL
(	NULL
cytoplasmic	NULL
plus	NULL
nuclear	NULL
)	NULL
were	NULL
detectably	NULL
enhanced	NULL
in	NULL
PF-treated	NULL
cells	NULL
(	NULL
for	NULL
example	NULL
in	NULL
Figure	NULL
8B	NULL
compare	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
with	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
an	NULL
effect	NULL
of	NULL
PF	NULL
on	NULL
c-Rel	NULL
induction	NULL
in	NULL
B	NULL
cells	NULL
was	NULL
further	NULL
confirmed	NULL
in	NULL
primary	NULL
splenic	NULL
B	NULL
cells	NULL
activated	NULL
with	NULL
either	NULL
phorbol	NULL
ester	NULL
plus	NULL
ionomycin	NULL
or	NULL
anti-immunoglobulin	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Phorbol	NULL
ester	NULL
and	NULL
ionomycin	NULL
treatment	NULL
strongly	NULL
induced	NULL
nuclear	NULL
Rel	NULL
B	NULL
expression	NULL
(	NULL
Figure	NULL
8C	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
,	NULL
which	NULL
was	NULL
unaffected	NULL
by	NULL
either	NULL
PF	NULL
or	NULL
FK506	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
whereas	NULL
most	NULL
of	NULL
the	NULL
newly	NULL
expressed	NULL
Rel	NULL
B	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
was	NULL
located	NULL
in	NULL
the	NULL
cytoplasmic	NULL
fraction	NULL
(	NULL
Figure	NULL
2B	NULL
)	NULL
,	NULL
most	NULL
of	NULL
the	NULL
Rel	NULL
B	NULL
in	NULL
activated	NULL
B	NULL
cells	NULL
was	NULL
found	NULL
in	NULL
the	NULL
nuclear	NULL
fraction	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
nuclear	NULL
translocation	NULL
of	NULL
Rel	NULL
B	NULL
may	NULL
be	NULL
differently	NULL
regulated	NULL
in	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
PF	NULL
suppresses	NULL
c-Rel	NULL
induction	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

This	NULL
observation	NULL
suggests	NULL
that	NULL
PF	NULL
Regulation	NULL
of	NULL
Rel	NULL
Proteins	NULL
in	NULL
Lymphocytes	NULL
Untreated	NULL
P+I+FK506	NULL
Untreated	NULL
P+I+FK506	NULL
P+l	NULL
C	NULL
N	NULL
c	NULL
N	NULL
C	NULL
101	NULL
83	NULL
51	NULL
4	NULL
35	NULL
1	NULL
2	NULL
3	NULL
4	NULL
10	NULL
20	NULL
3	NULL
4	NULL
Untreated	NULL
P+I+FK506	NULL
P+l+PF	NULL
C	NULL
N	NULL
C	NULL
N	NULL
C	NULL
N	NULL
C	NULL
N	NULL
101	NULL
83	NULL
51	NULL
-	NULL
-	NULL
dk	NULL
_	NULL
dum	NULL
-	NULL
sae	NULL
35	NULL
1020	NULL
3	NULL
40	NULL
50	NULL
60	NULL
7T	NULL
8	NULL
may	NULL
be	NULL
used	NULL
to	NULL
manipulate	NULL
T	NULL
cell	NULL
activation	NULL
without	NULL
affecting	NULL
B	NULL
cell	NULL
responses	NULL
.	NULL

Discussion	NULL
In	NULL
this	NULL
report	NULL
we	NULL
describe	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
drug	NULL
PF	NULL
on	NULL
lymphocyte	NULL
activation	NULL
.	NULL

In	NULL
T	NULL
cells	NULL
,	NULL
three	NULL
general	NULL
features	NULL
were	NULL
noted	NULL
.	NULL

First	NULL
,	NULL
PF	NULL
suppressed	NULL
the	NULL
induction	NULL
of	NULL
c-Rel	NULL
protein	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
via	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
or	NULL
its	NULL
pharmacologic	NULL
equivalent	NULL
,	NULL
phorbol	NULL
ester	NULL
and	NULL
ionomycin	NULL
.	NULL

Its	NULL
effect	NULL
on	NULL
the	NULL
other	NULL
Rel	NULL
family	NULL
proteins	NULL
was	NULL
more	NULL
variable	NULL
,	NULL
with	NULL
induction	NULL
of	NULL
Rel	NULL
B	NULL
being	NULL
virtually	NULL
unaffected	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
p50/p65	NULL
)	NULL
depending	NULL
on	NULL
the	NULL
cells	NULL
examined	NULL
.	NULL

Specifically	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
was	NULL
unimpaired	NULL
in	NULL
PF-treated	NULL
splenic	NULL
T	NULL
cells	NULL
,	NULL
but	NULL
significantly	NULL
reduced	NULL
in	NULL
D5h3	NULL
hybridoma	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
unlikely	NULL
that	NULL
the	NULL
effect	NULL
in	NULL
D5h3	NULL
cells	NULL
was	NULL
solely	NULL
due	NULL
to	NULL
its	NULL
transformed	NULL
nature	NULL
,	NULL
because	NULL
anti-CD3-induced	NULL
NF-kB	NULL
was	NULL
also	NULL
suppressed	NULL
in	NULL
the	NULL
Th1	NULL
clone	NULL
AEZ	NULL
(	NULL
W.	NULL
W.	NULL
,	NULL
T.	NULL
L.	NULL
Rothstein	NULL
,	NULL
and	NULL
R.	NULL
S.	NULL
,	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
induction	NULL
of	NULL
NF-AT	NULL
or	NULL
AP-1	NULL
was	NULL
not	NULL
suppressed	NULL
by	NULL
PF	NULL
.	NULL

We	NULL
previously	NULL
showed	NULL
that	NULL
c-Rel	NULL
and	NULL
NF-AT	NULL
shared	NULL
indistinguishable	NULL
activation	NULL
characteristics	NULL
,	NULL
both	NULL
requiring	NULL
the	NULL
dual	NULL
signal	NULL
of	NULL
phorbol	NULL
ester	NULL
plus	NULL
ionomycin	NULL
,	NULL
both	NULL
requiring	NULL
new	NULL
protein	NULL
synthesis	NULL
,	NULL
and	NULL
both	NULL
proteins	NULL
being	NULL
inhibited	NULL
by	NULL
the	NULL
immunosuppressive	NULL
drug	NULL
FK506	NULL
.	NULL

Our	NULL
present	NULL
findings	NULL
show	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
these	NULL
two	NULL
key	NULL
regulatory	NULL
proteins	NULL
can	NULL
be	NULL
distinguished	NULL
by	NULL
PF	NULL
.	NULL

Furthermore	NULL
,	NULL
PF	NULL
must	NULL
affect	NULL
the	NULL
c-Rel	NULL
activation	NULL
pathway	NULL
downstream	NULL
of	NULL
calcineurin	NULL
,	NULL
because	NULL
continued	NULL
NF-AT	NULL
induction	NULL
suggests	NULL
that	NULL
calcineurin	NULL
activation	NULL
is	NULL
unaffected	NULL
by	NULL
this	NULL
drug	NULL
.	NULL

Third	NULL
,	NULL
induction	NULL
of	NULL
IL-2	NULL
gene	NULL
,	NULL
but	NULL
not	NULL
the	NULL
IL-2Re	NULL
gene	NULL
,	NULL
was	NULL
blocked	NULL
by	NULL
PF	NULL
.	NULL

In	NULL
contrast	NULL
with	NULL
the	NULL
observations	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
found	NULL
that	NULL
c-Rel	NULL
induction	NULL
was	NULL
not	NULL
blocked	NULL
by	NULL
PF	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
greater	NULL
specificity	NULL
of	NULL
PF	NULL
compared	NULL
with	NULL
FK506	NULL
is	NULL
reflected	NULL
both	NULL
at	NULL
the	NULL
molecular	NULL
level	NULL
(	NULL
suppression	NULL
of	NULL
N	NULL
<	NULL
RelB	NULL
C	NULL
MCAI	NULL
5	NULL
6	NULL
7	NULL
8	NULL
Figure	NULL
8	NULL
.	NULL

Effect	NULL
of	NULL
PF	NULL
on	NULL
the	NULL
Induction	NULL
of	NULL
Rel	NULL
Family	NULL
Proteins	NULL
in	NULL
Bal	NULL
17	NULL
B	NULL
Cells	NULL
{	NULL
A	NULL
)	NULL
Analysis	NULL
of	NULL
NF-kB	NULL
DNA	NULL
binding	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
Bal	NULL
17	NULL
B	NULL
lymphoma	NULL
cells	NULL
activated	NULL
with	NULL
phorbol	NULL
ester	NULL
and	NULL
N	NULL
ionomycin	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
FK506	NULL
or	NULL
PF	NULL
,	NULL
as	NULL
indicated	NULL
above	NULL
the	NULL
lanes	NULL
.	NULL

The	NULL
H2K	NULL
probe	NULL
was	NULL
used	NULL
for	NULL
EMSA	NULL
;	NULL
the	NULL
arrow	NULL
indicates	NULL
the	NULL
position	NULL
of	NULL
the	NULL
inducible	NULL
NF-kB-DNA	NULL
complex	NULL
.	NULL

Lane	NULL
1	NULL
shows	NULL
the	NULL
constitutive	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
that	NULL
is	NULL
characteristic	NULL
of	NULL
mature	NULL
B	NULL
cells	NULL
.	NULL

{	NULL
B	NULL
and	NULL
C	NULL
)	NULL
Expression	NULL
of	NULL
c-Rel	NULL
and	NULL
Rel	NULL
B	NULL
proteins	NULL
.	NULL

Nuclear	NULL
(	NULL
N	NULL
)	NULL
or	NULL
cytoplasmic	NULL
(	NULL
C	NULL
)	NULL
extracts	NULL
{	NULL
6	NULL
ug	NULL
)	NULL
were	NULL
fractionated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
,	NULL
and	NULL
probed	NULL
with	NULL
anti-c-Rel	NULL
or	NULL
anti-Rel	NULL
B	NULL
antiserum	NULL
.	NULL

Positions	NULL
of	NULL
c-Rel	NULL
and	NULL
Rel	NULL
B	NULL
proteins	NULL
are	NULL
indicated	NULL
by	NULL
the	NULL
arrows	NULL
.	NULL

P+I+PF	NULL
only	NULL
c-Rel	NULL
,	NULL
and	NULL
not	NULL
NF-AT	NULL
,	NULL
in	NULL
T	NULL
cells	NULL
)	NULL
and	NULL
at	NULL
the	NULL
cellular	NULL
level	NULL
(	NULL
c-Rel	NULL
suppression	NULL
occurs	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
in	NULL
B	NULL
cells	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
mechanistic	NULL
basis	NULL
for	NULL
the	NULL
differential	NULL
effect	NULL
of	NULL
PF	NULL
on	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
is	NULL
not	NULL
yet	NULL
understood	NULL
,	NULL
two	NULL
alternative	NULL
models	NULL
could	NULL
account	NULL
for	NULL
these	NULL
observa-tions	NULL
.	NULL

First	NULL
,	NULL
c-Rel	NULL
may	NULL
be	NULL
induced	NULL
by	NULL
different	NULL
pathways	NULL
in	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
,	NULL
with	NULL
only	NULL
the	NULL
T	NULL
cell	NULL
pathway	NULL
being	NULL
sensitive	NULL
to	NULL
PF	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
induction	NULL
pathway	NULL
may	NULL
be	NULL
the	NULL
same	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
,	NULL
but	NULL
B	NULL
cells	NULL
may	NULL
have	NULL
compensatory	NULL
mechanisms	NULL
to	NULL
circumvent	NULL
the	NULL
block	NULL
by	NULL
PF	NULL
.	NULL

Several	NULL
lines	NULL
of	NULL
evidence	NULL
make	NULL
us	NULL
favor	NULL
the	NULL
second	NULL
model	NULL
.	NULL

First	NULL
,	NULL
the	NULL
requirements	NULL
for	NULL
c-Rel	NULL
induction	NULL
are	NULL
similar	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
(	NULL
Venkataraman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
,	NULL
suggesting	NULL
a	NULL
common	NULL
mechanism	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
this	NULL
gene	NULL
.	NULL

Second	NULL
,	NULL
with	NULL
respect	NULL
to	NULL
NF-kB	NULL
proteins	NULL
,	NULL
the	NULL
physiology	NULL
of	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
differ	NULL
in	NULL
at	NULL
least	NULL
three	NULL
ways	NULL
:	NULL
B	NULL
cells	NULL
contain	NULL
constitutively	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
whereas	NULL
T	NULL
cells	NULL
do	NULL
not	NULL
;	NULL
B	NULL
cells	NULL
rapidly	NULL
translocate	NULL
cytoplasmic	NULL
c-Rel	NULL
,	NULL
whereas	NULL
T	NULL
cells	NULL
do	NULL
not	NULL
(	NULL
Venkataraman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
;	NULL
and	NULL
Rel	NULL
B	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
is	NULL
more	NULL
efficient	NULL
in	NULL
B	NULL
cells	NULL
compared	NULL
with	NULL
T	NULL
cells	NULL
(	NULL
see	NULL
Figures	NULL
2B	NULL
and	NULL
7C	NULL
)	NULL
.	NULL

Regardless	NULL
of	NULL
the	NULL
mechanism	NULL
,	NULL
these	NULL
observations	NULL
suggest	NULL
that	NULL
PF	NULL
may	NULL
be	NULL
used	NULL
to	NULL
manipulate	NULL
T	NULL
cell	NULL
responses	NULL
selectively	NULL
in	NULL
vivo	NULL
.	NULL

Our	NULL
studies	NULL
have	NULL
other	NULL
interesting	NULL
implications	NULL
.	NULL

We	NULL
chose	NULL
to	NULL
analyze	NULL
IL-2	NULL
and	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
expression	NULL
to	NULL
get	NULL
an	NULL
idea	NULL
of	NULL
the	NULL
consequences	NULL
of	NULL
transcription	NULL
factor	NULL
dysregulation	NULL
by	NULL
PF	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
both	NULL
transformed	NULL
and	NULL
untransformed	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
found	NULL
that	NULL
IL-2Ra	NULL
expression	NULL
was	NULL
essentially	NULL
unaffected	NULL
,	NULL
whereas	NULL
IL-2	NULL
gene	NULL
induction	NULL
was	NULL
abolished	NULL
.	NULL

The	NULL
regulatory	NULL
sequence	NULL
that	NULL
governs	NULL
IL-2R	NULL
«	NULL
induction	NULL
depends	NULL
primarily	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
serum	NULL
response	NULL
factor-binding	NULL
sites	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
this	NULL
inducible	NULL
enhancer	NULL
can	NULL
be	NULL
synergistically	NULL
transactivated	NULL
by	NULL
serum	NULL
response	NULL
factor	NULL
together	NULL
with	NULL
either	NULL
p65	NULL
or	NULL
a	NULL
p50/c-Rel	NULL
heterodimer	NULL
(	NULL
Pierce	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Because	NULL
IL-2Ra	NULL
Immunity	NULL
172	NULL
expression	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
PF	NULL
whereas	NULL
c-Relinduc-tion	NULL
was	NULL
diminished	NULL
,	NULL
we	NULL
propose	NULL
that	NULL
c-Rel	NULL
is	NULL
not	NULL
the	NULL
major	NULL
IL-2Ra	NULL
kB	NULL
site-binding	NULL
protein	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

Continued	NULL
IL-2Ra	NULL
gene	NULL
induction	NULL
even	NULL
when	NULL
NF-kB	NULL
levels	NULL
were	NULL
low	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
suggested	NULL
that	NULL
these	NULL
low	NULL
levels	NULL
may	NULL
be	NULL
sufficient	NULL
for	NULL
gene	NULL
induction	NULL
or	NULL
that	NULL
strong	NULL
transactivators	NULL
with	NULL
low	NULL
binding	NULL
affinities	NULL
(	NULL
such	NULL
as	NULL
p65	NULL
homo-dimers	NULL
,	NULL
which	NULL
would	NULL
be	NULL
difficult	NULL
to	NULL
detect	NULL
in	NULL
these	NULL
binding	NULL
assays	NULL
)	NULL
may	NULL
be	NULL
directing	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
expression	NULL
.	NULL

Results	NULL
with	NULL
the	NULL
IL-2	NULL
gene	NULL
are	NULL
exactly	NULL
reversed	NULL
:	NULL
gene	NULL
induction	NULL
is	NULL
suppressed	NULL
independent	NULL
of	NULL
the	NULL
levels	NULL
of	NULL
NF-kB	NULL
.	NULL

Extensive	NULL
analysis	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
has	NULL
identified	NULL
three	NULL
main	NULL
categories	NULL
of	NULL
inducible	NULL
protein-binding	NULL
sites	NULL
:	NULL
NF-AT	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
NF-kB	NULL
.	NULL

Because	NULL
neither	NULL
DNA	NULL
binding	NULL
nor	NULL
transcriptional	NULL
activation	NULL
by	NULL
NF-AT	NULL
and	NULL
AP-1	NULL
was	NULL
affected	NULL
by	NULL
PF	NULL
,	NULL
and	NULL
the	NULL
effects	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
were	NULL
variable	NULL
,	NULL
the	NULL
simplest	NULL
interpretation	NULL
of	NULL
our	NULL
observations	NULL
is	NULL
that	NULL
the	NULL
IL-2	NULL
promoter	NULL
is	NULL
a	NULL
target	NULL
of	NULL
c-Rel	NULL
.	NULL

Although	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
induced	NULL
c-Rel	NULL
activates	NULL
other	NULL
transcription	NULL
factor	NULL
genes	NULL
that	NULL
are	NULL
the	NULL
functional	NULL
IL-2	NULL
promoter	NULL
factors	NULL
,	NULL
the	NULL
similar	NULL
time	NULL
course	NULL
of	NULL
IL-2	NULL
and	NULL
c-Rel	NULL
activation	NULL
leads	NULL
us	NULL
to	NULL
propose	NULL
that	NULL
c-Rel	NULL
is	NULL
the	NULL
functional	NULL
Rel	NULL
protein	NULL
that	NULL
activates	NULL
IL-2	NULL
transcription	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
,	NULL
we	NULL
found	NULL
that	NULL
c-Rel	NULL
acted	NULL
synergistically	NULL
with	NULL
NF-AT	NULL
;	NULL
to	NULL
activate	NULL
the	NULL
IL-2	NULL
promoter	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
in	NULL
nonlymphoid	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
not	NULL
our	NULL
intent	NULL
to	NULL
suggest	NULL
that	NULL
c-Rel	NULL
and	NULL
NF-AT	NULL
are	NULL
the	NULL
only	NULL
IL-2	NULL
promoter	NULL
factors	NULL
or	NULL
that	NULL
the	NULL
complete	NULL
activity	NULL
of	NULL
the	NULL
promoter	NULL
has	NULL
been	NULL
reconstituted	NULL
in	NULL
our	NULL
experiments	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
note	NULL
that	NULL
the	NULL
possibility	NULL
that	NULL
PF	NULL
affects	NULL
a	NULL
previously	NULL
unidentified	NULL
IL-2	NULL
promoter	NULL
factor	NULL
can	NULL
not	NULL
be	NULL
unequivocally	NULL
ruled	NULL
out	NULL
.	NULL

Families	NULL
of	NULL
transcription	NULL
factors	NULL
often	NULL
share	NULL
similar	NULL
DNA	NULL
recognition	NULL
sites	NULL
;	NULL
consequently	NULL
it	NULL
has	NULL
been	NULL
difficult	NULL
to	NULL
identify	NULL
gene	NULL
targets	NULL
of	NULL
specific	NULL
family	NULL
members	NULL
.	NULL

Our	NULL
proposal	NULL
that	NULL
the	NULL
IL-2	NULL
gene	NULL
may	NULL
be	NULL
regulated	NULL
primarily	NULL
by	NULL
c-Rel	NULL
and	NULL
the	NULL
IL-2R	NULL
«	NULL
gene	NULL
by	NULL
p65	NULL
provides	NULL
an	NULL
intriguing	NULL
insight	NULL
into	NULL
the	NULL
division	NULL
of	NULL
labor	NULL
among	NULL
Rel	NULL
family	NULL
proteins	NULL
during	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Our	NULL
results	NULL
are	NULL
also	NULL
consistent	NULL
with	NULL
the	NULL
activation	NULL
phenotype	NULL
of	NULL
c-Rel-deficient	NULL
animals	NULL
(	NULL
Kontgen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Kontgen	NULL
et	NULL
al	NULL
.	NULL

showed	NULL
that	NULL
B	NULL
and	NULL
T	NULL
lymphocytes	NULL
from	NULL
c-Rel-deficient	NULL
mice	NULL
did	NULL
not	NULL
proliferate	NULL
in	NULL
response	NULL
to	NULL
signals	NULL
initiated	NULL
at	NULL
the	NULL
respective	NULL
antigen	NULL
receptors	NULL
.	NULL

In	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
effect	NULL
was	NULL
primarily	NULL
due	NULL
to	NULL
lack	NULL
of	NULL
IL-2	NULL
synthesis	NULL
,	NULL
whereas	NULL
IL-2Ra	NULL
induction	NULL
was	NULL
not	NULL
affected	NULL
.	NULL

Our	NULL
studies	NULL
with	NULL
normal	NULL
mature	NULL
T	NULL
cells	NULL
complement	NULL
the	NULL
analysis	NULL
of	NULL
c-Rel	NULL
'~	NULL
animals	NULL
and	NULL
argue	NULL
against	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
lack	NULL
of	NULL
proliferation	NULL
in	NULL
c-Rel'~	NULL
animals	NULL
is	NULL
due	NULL
to	NULL
a	NULL
developmental	NULL
defect	NULL
caused	NULL
by	NULL
the	NULL
lack	NULL
of	NULL
c-Rel	NULL
.	NULL

We	NULL
do	NULL
not	NULL
mean	NULL
to	NULL
imply	NULL
that	NULL
Rel	NULL
family	NULL
members	NULL
never	NULL
compensate	NULL
for	NULL
each	NULL
other	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
endogenous	NULL
IL-2Ra	NULL
«	NULL
promoter	NULL
is	NULL
also	NULL
activated	NULL
by	NULL
c-Rel	NULL
protein	NULL
,	NULL
as	NULL
has	NULL
been	NULL
observed	NULL
in	NULL
transactivation	NULL
assays	NULL
.	NULL

However	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
c-Rel	NULL
,	NULL
another	NULL
Rel	NULL
protein	NULL
(	NULL
most	NULL
probably	NULL
p65	NULL
)	NULL
is	NULL
clearly	NULL
sufficient	NULL
for	NULL
gene	NULL
induction	NULL
.	NULL

That	NULL
this	NULL
is	NULL
not	NULL
the	NULL
case	NULL
for	NULL
IL-2	NULL
suggests	NULL
a	NULL
more	NULL
strict	NULL
requirement	NULL
for	NULL
a	NULL
specific	NULL
Rel	NULL
family	NULL
protein	NULL
for	NULL
IL-2	NULL
promoter	NULL
activity	NULL
,	NULL
presumably	NULL
to	NULL
coordinate	NULL
interactions	NULL
with	NULL
other	NULL
promoter	NULL
factors	NULL
.	NULL

Based	NULL
on	NULL
its	NULL
chemical	NULL
structure	NULL
,	NULL
PF	NULL
is	NULL
believed	NULL
to	NULL
function	NULL
as	NULL
a	NULL
phosphodiesterase	NULL
inhibitor	NULL
that	NULL
raises	NULL
intracellular	NULL
cyclic	NULL
AMP	NULL
(	NULL
cAMP	NULL
)	NULL
levels	NULL
.	NULL

Although	NULL
this	NULL
may	NULL
be	NULL
true	NULL
in	NULL
some	NULL
situations	NULL
,	NULL
several	NULL
observations	NULL
suggest	NULL
that	NULL
this	NULL
may	NULL
not	NULL
be	NULL
its	NULL
only	NULL
mode	NULL
of	NULL
action	NULL
.	NULL

For	NULL
example	NULL
,	NULL
PF	NULL
can	NULL
augment	NULL
differentiation	NULL
of	NULL
a	NULL
neuroblastoma	NULL
cell	NULL
line	NULL
,	NULL
but	NULL
this	NULL
activity	NULL
was	NULL
not	NULL
mimicked	NULL
by	NULL
cAMP	NULL
(	NULL
Yang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
;	NULL
PF	NULL
did	NULL
not	NULL
cause	NULL
a	NULL
significant	NULL
increase	NULL
of	NULL
intracellular	NULL
cAMP	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
,	NULL
whereas	NULL
the	NULL
combined	NULL
action	NULL
of	NULL
PF	NULL
plus	NULL
prostanoids	NULL
did	NULL
elevate	NULL
cAMP	NULL
levels	NULL
in	NULL
the	NULL
same	NULL
cells	NULL
(	NULL
Sinha	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
;	NULL
in	NULL
702	NULL
pre-B	NULL
cells	NULL
,	NULL
cAMP	NULL
has	NULL
been	NULL
found	NULL
to	NULL
activate	NULL
x	NULL
light	NULL
chain	NULL
expression	NULL
(	NULL
Shirakawa	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
,	NULL
whereas	NULL
we	NULL
found	NULL
that	NULL
PF	NULL
inhibited	NULL
LPS-mediated	NULL
k	NULL
expression	NULL
(	NULL
W.	NULL
W.	NULL
,	NULL
J.	NULL
Durdik	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
and	NULL
R.	NULL
S.	NULL
,	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
peripheral	NULL
human	NULL
T	NULL
lymphocytes	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
PF	NULL
were	NULL
not	NULL
blocked	NULL
by	NULL
HA1004	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
cAMP-dependent	NULL
protein	NULL
kinase	NULL
(	NULL
Rao	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
mechanism	NULL
of	NULL
PF	NULL
action	NULL
remains	NULL
unclear	NULL
.	NULL

It	NULL
has	NULL
been	NULL
previously	NULL
shown	NULL
that	NULL
cAMP	NULL
and	NULL
cAMP	NULL
agonists	NULL
such	NULL
as	NULL
prostaglandin	NULL
E1	NULL
and	NULL
E2	NULL
inhibit	NULL
IL-2	NULL
gene	NULL
induction	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
molecular	NULL
mechanism	NULL
of	NULL
inhibition	NULL
by	NULL
cAMP	NULL
has	NULL
been	NULL
investigated	NULL
in	NULL
EL-4	NULL
cells	NULL
and	NULL
found	NULL
to	NULL
correlate	NULL
with	NULL
NF-kB	NULL
(	NULL
Chen	NULL
and	NULL
Rothenberg	NULL
,	NULL
1994	NULL
)	NULL
and	NULL
,	NULL
in	NULL
particular	NULL
,	NULL
the	NULL
Rel	NULL
A	NULL
component	NULL
of	NULL
NF-kB	NULL
(	NULL
Neuman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

However	NULL
,	NULL
as	NULL
described	NULL
above	NULL
,	NULL
we	NULL
found	NULL
that	NULL
PF	NULL
had	NULL
variable	NULL
effects	NULL
on	NULL
Rel	NULL
A	NULL
,	NULL
but	NULL
consistently	NULL
inhibited	NULL
c-Rel	NULL
induction	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Based	NULL
on	NULL
these	NULL
observations	NULL
,	NULL
we	NULL
consider	NULL
it	NULL
likely	NULL
that	NULL
PF	NULL
action	NULL
on	NULL
T	NULL
cells	NULL
is	NULL
amore	NULL
complex	NULL
phenomenon	NULL
than	NULL
simply	NULL
raising	NULL
intracellular	NULL
cAMP	NULL
.	NULL

A	NULL
possible	NULL
relationship	NULL
of	NULL
PF	NULL
to	NULL
calcium	NULL
mobilization	NULL
(	NULL
Yang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
is	NULL
particularly	NULL
interesting	NULL
because	NULL
optimal	NULL
c-Rel	NULL
induction	NULL
requires	NULL
the	NULL
dual	NULL
signal	NULL
of	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
.	NULL

PF	NULL
may	NULL
therefore	NULL
inhibit	NULL
c-Rel	NULL
induction	NULL
by	NULL
attenuating	NULL
a	NULL
component	NULL
of	NULL
the	NULL
calcium	NULL
response	NULL
.	NULL

Experimental	NULL
Procedures	NULL
Cells	NULL
and	NULL
Cell	NULL
Activation	NULL
D5h3	NULL
(	NULL
T	NULL
)	NULL
cells	NULL
and	NULL
Bal	NULL
17	NULL
(	NULL
B	NULL
)	NULL
cells	NULL
were	NULL
grown	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Venkataraman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Concanavalin	NULL
A	NULL
(	NULL
ConA	NULL
)	NULL
blasts	NULL
of	NULL
splenic	NULL
T	NULL
cells	NULL
were	NULL
prepared	NULL
by	NULL
activating	NULL
a	NULL
single	NULL
cell	NULL
suspension	NULL
of	NULL
spleen	NULL
cells	NULL
with	NULL
2	NULL
ug/ml	NULL
ConA	NULL
(	NULL
Calbiochem	NULL
)	NULL
in	NULL
DMEM	NULL
,	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
penicillin	NULL
,	NULL
and	NULL
streptomycin	NULL
for	NULL
3	NULL
days	NULL
.	NULL

IL-2	NULL
(	NULL
10	NULL
U/ml	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
cultures	NULL
every	NULL
2	NULL
days	NULL
.	NULL

After	NULL
approximately	NULL
7	NULL
days	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
rested	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
ConA	NULL
or	NULL
IL-2	NULL
for	NULL
16	NULL
hr	NULL
prior	NULL
to	NULL
activation	NULL
.	NULL

For	NULL
cell	NULL
activation	NULL
,	NULL
phorbol	NULL
ester	NULL
(	NULL
Sigma	NULL
)	NULL
and	NULL
ionomycin	NULL
(	NULL
Calbiochem	NULL
)	NULL
were	NULL
used	NULL
at	NULL
50	NULL
ng/ml	NULL
and	NULL
2	NULL
wM	NULL
,	NULL
respectively	NULL
.	NULL

CD3	NULL
cross-linking	NULL
was	NULL
carried	NULL
out	NULL
using	NULL
plate-bound	NULL
antibody	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
a	NULL
solution	NULL
of	NULL
rabbit	NULL
anti-hamster	NULL
(	NULL
Cappel	NULL
)	NULL
antibodies	NULL
in	NULL
PBS	NULL
(	NULL
100	NULL
pg/ml	NULL
)	NULL
was	NULL
placed	NULL
in	NULL
6-well	NULL
tissue	NULL
culture	NULL
dishes	NULL
for	NULL
12	NULL
hr	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
removed	NULL
,	NULL
and	NULL
the	NULL
plates	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
cold	NULL
PBS	NULL
to	NULL
remove	NULL
unbound	NULL
antibody	NULL
.	NULL

Prior	NULL
to	NULL
cell	NULL
activation	NULL
,	NULL
anti-CD3	NULL
antibody	NULL
was	NULL
added	NULL
to	NULL
the	NULL
cells	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
6	NULL
g/ml	NULL
,	NULL
followed	NULL
by	NULL
addition	NULL
of	NULL
cells	NULL
at	NULL
a	NULL
density	NULL
of	NULL
5	NULL
X	NULL
10°	NULL
per	NULL
milliliter	NULL
in	NULL
complete	NULL
medium	NULL
.	NULL

After	NULL
activation	NULL
,	NULL
cells	NULL
were	NULL
scraped	NULL
off	NULL
the	NULL
plates	NULL
with	NULL
a	NULL
rubber	NULL
policeman	NULL
,	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
PBS	NULL
(	NULL
4°C	NULL
)	NULL
,	NULL
and	NULL
used	NULL
to	NULL
prepare	NULL
RNA	NULL
or	NULL
nuclear	NULL
extracts	NULL
.	NULL

For	NULL
drug	NULL
treatment	NULL
,	NULL
PF	NULL
at	NULL
300	NULL
g/ml	NULL
or	NULL
FK506	NULL
at	NULL
2	NULL
nM	NULL
was	NULL
added	NULL
to	NULL
the	NULL
cultures	NULL
10	NULL
min	NULL
prior	NULL
to	NULL
activation	NULL
.	NULL

PF	NULL
concentration	NULL
was	NULL
chosen	NULL
based	NULL
on	NULL
earlier	NULL
studies	NULL
that	NULL
used	NULL
this	NULL
drug	NULL
at	NULL
doses	NULL
of	NULL
150-900	NULL
pg/ml	NULL
!	NULL

(	NULL
Biswas	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993a	NULL
,	NULL
1993b	NULL
;	NULL
Rao	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Streiter	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

In	NULL
our	NULL
own	NULL
dose-response	NULL
titrations	NULL
,	NULL
the	NULL
observed	NULL
effects	NULL
were	NULL
significantly	NULL
reduced	NULL
at	NULL
150	NULL
pg/ml	NULL
and	NULL
unchanged	NULL
at	NULL
higher	NULL
(	NULL
600	NULL
g/m	NULL
!	NULL
)	NULL

drug	NULL
concentrations	NULL
.	NULL

Nuclear	NULL
Extracts	NULL
,	NULL
EMSA	NULL
,	NULL
and	NULL
Western	NULL
Blots	NULL
All	NULL
procedures	NULL
have	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
Venkataraman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Probes	NULL
for	NULL
EMSA	NULL
were	NULL
the	NULL
H2K	NULL
(	NULL
Mauxion	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Regulation	NULL
of	NULL
Rel	NULL
Proteins	NULL
in	NULL
Lymphocytes	NULL
Mauxion	NULL
and	NULL
Sen	NULL
,	NULL
1989	NULL
)	NULL
kB	NULL
sequence	NULL
and	NULL
the	NULL
murine	NULL
NF-AT	NULL
sequence	NULL
that	NULL
we	NULL
used	NULL
previously	NULL
(	NULL
Venkataraman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

For	NULL
immunoblotting	NULL
,	NULL
anti-c-Rel	NULL
antibodies	NULL
(	NULL
SC	NULL
71	NULL
;	NULL
Santa	NULL
Cruz	NULL
Biotech-nology	NULL
)	NULL
and	NULL
anti-Rel	NULL
B	NULL
antibodies	NULL
(	NULL
SC	NULL
226	NULL
%	NULL
;	NULL
Santa	NULL
Cruz	NULL
Biotechnol-ogy	NULL
)	NULL
were	NULL
used	NULL
at	NULL
a	NULL
1:500	NULL
dilution	NULL
.	NULL

Northern	NULL
Blots	NULL
Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
using	NULL
the	NULL
ultraspec	NULL
(	NULL
Biotecx	NULL
Labora-tories	NULL
,	NULL
Houston	NULL
,	NULL
TX	NULL
)	NULL
RNA	NULL
isolation	NULL
solution	NULL
procedure	NULL
,	NULL
and	NULL
10	NULL
ug	NULL
was	NULL
fractionated	NULL
through	NULL
1	NULL
%	NULL
agarose	NULL
gels	NULL
containing	NULL
formaldehyde	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
filters	NULL
.	NULL

Prehybridization	NULL
was	NULL
carried	NULL
out	NULL
for	NULL
30	NULL
min	NULL
in	NULL
50	NULL
%	NULL
deionized	NULL
formamide	NULL
,	NULL
5x	NULL
SSPE	NULL
,	NULL
5	NULL
%	NULL
Denhardt	NULL
's	NULL
solution	NULL
,	NULL
0.5	NULL
%	NULL
SDS	NULL
,	NULL
100	NULL
ug/ml	NULL
salmon	NULL
sperm	NULL
DNA	NULL
at	NULL
42°C	NULL
.	NULL

Probes	NULL
{	NULL
described	NULL
below	NULL
)	NULL
were	NULL
radiolabeled	NULL
by	NULL
random	NULL
priming	NULL
and	NULL
used	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
2	NULL
x	NULL
10°	NULL
cpm	NULL
per	NULL
milliliter	NULL
of	NULL
hybridization	NULL
buffer	NULL
.	NULL

Probes	NULL
Probes	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
IL-2	NULL
,	NULL
a	NULL
900	NULL
bp	NULL
Pst	NULL
!	NULL

fragment	NULL
was	NULL
isolated	NULL
from	NULL
pIL-2-sense	NULL
(	NULL
gift	NULL
of	NULL
Dr.	NULL
B.	NULL
Huber	NULL
,	NULL
Tufts	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
}	NULL
;	NULL
IL-2Ra	NULL
,	NULL
1	NULL
kb	NULL
EcoRl-Xbal	NULL
fragment	NULL
containing	NULL
the	NULL
murine	NULL
IL-2Ra	NULL
cDNA	NULL
was	NULL
isolated	NULL
from	NULL
pGEM-1-R8-1000Exb	NULL
(	NULL
Miller	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
;	NULL
gift	NULL
of	NULL
Dr.	NULL
A.	NULL
Rao	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
}	NULL
;	NULL
GAPDH	NULL
,	NULL
a	NULL
750	NULL
Pstl-Kpnl	NULL
fragment	NULL
was	NULL
isolated	NULL
from	NULL
pBSKII*	NULL
rat	NULL
GAPDH	NULL
clone	NULL
(	NULL
gift	NULL
of	NULL
Dr.	NULL
M.	NULL
Baron	NULL
,	NULL
Harvard	NULL
University	NULL
,	NULL
Cambridge	NULL
,	NULL
MAJ	NULL
}	NULL
.	NULL

Transient	NULL
Transfections	NULL
D5h3	NULL
{	NULL
T	NULL
hybridoma	NULL
}	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
reporter	NULL
plasmids	NULL
using	NULL
DEAE-dextran	NULL
(	NULL
Nelsen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

At	NULL
24	NULL
hr	NULL
posttransfection	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
phorbol	NULL
ester	NULL
,	NULL
ionomycin	NULL
,	NULL
and	NULL
PF	NULL
as	NULL
indicated	NULL
for	NULL
an	NULL
additional	NULL
4	NULL
hr	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
and	NULL
50	NULL
mug	NULL
of	NULL
whole-cell	NULL
extracts	NULL
was	NULL
assayed	NULL
for	NULL
CAT	NULL
enzyme	NULL
by	NULL
ELISA	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
.	NULL

293	NULL
(	NULL
human	NULL
embryonic	NULL
kidney	NULL
)	NULL
cells	NULL
were	NULL
transfected	NULL
using	NULL
calcium	NULL
phosphate	NULL
with	NULL
a	NULL
wild-type	NULL
IL-2	NULL
promoter	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
(	NULL
Hughes	NULL
and	NULL
Pober	NULL
,	NULL
1996	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
2	NULL
ug	NULL
of	NULL
expression	NULL
vectors	NULL
for	NULL
transactivators	NULL
c-Rel	NULL
and	NULL
NF-AT	NULL
;	NULL
{	NULL
Northrop	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Venkataraman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

When	NULL
no	NULL
or	NULL
only	NULL
one	NULL
transactivator	NULL
was	NULL
present	NULL
,	NULL
the	NULL
total	NULL
DNA	NULL
was	NULL
held	NULL
constant	NULL
at	NULL
6	NULL
g	NULL
using	NULL
an	NULL
expression	NULL
vector	NULL
containing	NULL
no	NULL
insert	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
in	NULL
lysis	NULL
buffer	NULL
48	NULL
hr	NULL
after	NULL
transfection	NULL
(	NULL
Analytic	NULL
Luminescence	NULL
Laboratory	NULL
,	NULL
Ann	NULL
Arbor	NULL
,	NULL
MI	NULL
)	NULL
,	NULL
and	NULL
20	NULL
ug	NULL
of	NULL
extract	NULL
was	NULL
used	NULL
for	NULL
the	NULL
luciferase	NULL
assay	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
normalized	NULL
to	NULL
that	NULL
seen	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
cotransfected	NULL
transactivator	NULL
plasmids	NULL
.	NULL

Acknowledgments	NULL
Correspondence	NULL
should	NULL
be	NULL
addressed	NULL
to	NULL
R.	NULL
S.	NULL
We	NULL
thank	NULL
Dr.	NULL
Steve	NULL
Burakoff	NULL
for	NULL
the	NULL
gift	NULL
of	NULL
FK506	NULL
used	NULL
in	NULL
these	NULL
studies	NULL
,	NULL
Dr.	NULL
Anjana	NULL
Rao	NULL
for	NULL
probes	NULL
and	NULL
protocols	NULL
for	NULL
growth	NULL
of	NULL
splenic	NULL
ConA	NULL
blasts	NULL
,	NULL
Dr.	NULL
Gerald	NULL
Crabtree	NULL
for	NULL
NF-AT	NULL
;	NULL
antisera	NULL
and	NULL
vector	NULL
,	NULL
Dr.	NULL
Henry	NULL
Wortis	NULL
for	NULL
NF-AT	NULL
,	NULL
antisera	NULL
,	NULL
Drs	NULL
.	NULL

Tom	NULL
Rothstein	NULL
and	NULL
Jyoti	NULL
Sen	NULL
for	NULL
helpful	NULL
discussions	NULL
,	NULL
and	NULL
Ms.	NULL
Elaine	NULL
Ames	NULL
for	NULL
preparation	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
,	NULL
in	NULL
part	NULL
,	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
grant	NULL
CAG66626	NULL
.	NULL

Received	NULL
August	NULL
19	NULL
,	NULL
1996	NULL
;	NULL
revised	NULL
December	NULL
18	NULL
,	NULL
1996	NULL
.	NULL

References	NULL
Bellas	NULL
,	NULL
R.E	NULL
.	NULL

,	NULL
Lee	NULL
,	NULL
J.S	NULL
.	NULL

,	NULL
and	NULL
Sonenshein	NULL
,	NULL
G.E	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
a	NULL
constitutive	NULL
NF-xB-like	NULL
activity	NULL
is	NULL
essential	NULL
for	NULL
proliferation	NULL
of	NULL
culture	NULL
bovine	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cells	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

96	NULL
,	NULL
2521-2527	NULL
.	NULL

Bemelmans	NULL
,	NULL
M.H	NULL
.	NULL

,	NULL
Abramowicz	NULL
,	NULL
D.	NULL
,	NULL
Gouma	NULL
,	NULL
D.J	NULL
.	NULL

,	NULL
Goldman	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Buurman	NULL
,	NULL
W.A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

in	NULL
vivo	NULL
T	NULL
cell	NULL
activation	NULL
by	NULL
anti-CD3	NULL
monoclonal	NULL
antibody	NULL
induces	NULL
soluble	NULL
TNF	NULL
receptor	NULL
release	NULL
in	NULL
mice	NULL
:	NULL
effects	NULL
of	NULL
pentoxifylline	NULL
,	NULL
methylprednisolone	NULL
,	NULL
anti-TNF	NULL
,	NULL
and	NULL
anti-IFN-y	NULL
antibodies	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153	NULL
,	NULL
499-506	NULL
.	NULL

Biswas	NULL
,	NULL
D.K	NULL
.	NULL

,	NULL
Dezube	NULL
,	NULL
B.J	NULL
.	NULL

,	NULL
Ahlers	NULL
,	NULL
C.M	NULL
.	NULL

,	NULL
and	NULL
Pardes	NULL
,	NULL
A.B	NULL
.	NULL

(	NULL
19932	NULL
)	NULL
.	NULL

Pentoxifylline	NULL
inhibits	NULL
HIV-1	NULL
LTR-drivengene	NULL
expression	NULL
by	NULL
blocking	NULL
NF-	NULL
«	NULL
B	NULL
action	NULL
.	NULL

J.	NULL
Acquir	NULL
.	NULL

Immune	NULL
Defic	NULL
.	NULL

Syndr	NULL
.	NULL

6	NULL
,	NULL
778-786	NULL
.	NULL

Biswas	NULL
,	NULL
D.K	NULL
.	NULL

,	NULL
Ahlers	NULL
,	NULL
C.M	NULL
.	NULL

,	NULL
Dezube	NULL
,	NULL
B.J	NULL
.	NULL

,	NULL
and	NULL
Pardes	NULL
,	NULL
A.B	NULL
.	NULL

(	NULL
1993b	NULL
)	NULL
.	NULL

Cooperative	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Tat-induced	NULL
superactivation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
,	NULL
11044-11048	NULL
.	NULL

Chen	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Rothenberg	NULL
,	NULL
EV	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Interleukin	NULL
2	NULL
transcription	NULL
factors	NULL
as	NULL
molecular	NULL
targets	NULL
of	NULL
cAMP	NULL
inhibition	NULL
:	NULL
delayed	NULL
inhibition	NULL
kinetics	NULL
and	NULL
combinatorial	NULL
transcription	NULL
roles	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

179	NULL
,	NULL
931-942	NULL
.	NULL

Cross	NULL
,	NULL
S.L	NULL
.	NULL

,	NULL
Halden	NULL
,	NULL
N.F	NULL
.	NULL

,	NULL
Lenardo	NULL
,	NULL
M.J.	NULL
,	NULL
and	NULL
Leonard	NULL
,	NULL
W.J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
.	NULL

Functionally	NULL
distinct	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
immunoglobulin	NULL
k	NULL
and	NULL
IL-2	NULL
receptor	NULL
a	NULL
chain	NULL
genes	NULL
.	NULL

Science	NULL
244	NULL
,	NULL
466-469	NULL
.	NULL

Emmel	NULL
,	NULL
EA	NULL
.	NULL

,	NULL
Verweij	NULL
,	NULL
C.L	NULL
.	NULL

,	NULL
Durand	NULL
,	NULL
D.B	NULL
.	NULL

,	NULL
Higgins	NULL
,	NULL
K.M	NULL
.	NULL

,	NULL
Lacy	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.R	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
.	NULL

Cyclosporin	NULL
A	NULL
specifically	NULL
inhibits	NULL
function	NULL
of	NULL
nuclear	NULL
proteins	NULL
involved	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Science	NULL
246	NULL
,	NULL
1617-1620	NULL
.	NULL

Flanagan	NULL
,	NULL
W.M	NULL
.	NULL

,	NULL
Corthesy	NULL
,	NULL
B.	NULL
,	NULL
Bram	NULL
,	NULL
R.J.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.R	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

Nuclear	NULL
association	NULL
of	NULL
a	NULL
T-cell	NULL
transcription	NULL
factor	NULL
blocked	NULL
by	NULL
FK506	NULL
and	NULL
cyclosporin	NULL
A	NULL
.	NULL

Nature	NULL
352	NULL
,	NULL
803-807	NULL
.	NULL

Fraser	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
Irving	NULL
,	NULL
B.A	NULL
.	NULL

,	NULL
Crabtree	NULL
,	NULL
G.R	NULL
.	NULL

,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

Regulation	NULL
of	NULL
interleukin-2	NULL
gene	NULL
enhancer	NULL
activity	NULL
by	NULL
the	NULL
T	NULL
cell	NULL
accessory	NULL
molecule	NULL
CD28	NULL
.	NULL

Science	NULL
251	NULL
,	NULL
313-316	NULL
.	NULL

Hughes	NULL
,	NULL
C.C	NULL
.	NULL

,	NULL
and	NULL
Pober	NULL
,	NULL
J.S	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
interleukin-2	NULL
gene	NULL
in	NULL
normal	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
:	NULL
convergence	NULL
of	NULL
costimulatory	NULL
signals	NULL
and	NULL
differences	NULL
from	NULL
transformed	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
5369-5377	NULL
.	NULL

Kiley	NULL
,	NULL
P.D	NULL
.	NULL

,	NULL
Gillespie	NULL
,	NULL
K.M	NULL
.	NULL

,	NULL
and	NULL
Oliveira	NULL
,	NULL
D.B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Oxpentifylline	NULL
inhibits	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
«	NULL
mRNA	NULL
transcription	NULL
and	NULL
protects	NULL
against	NULL
arthritis	NULL
in	NULL
mercuric	NULL
chloride-treated	NULL
brown	NULL
Norway	NULL
rats	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

25	NULL
,	NULL
2899-2906	NULL
.	NULL

Kontgen	NULL
,	NULL
F.	NULL
,	NULL
Grumont	NULL
,	NULL
R.J.	NULL
,	NULL
Strasser	NULL
,	NULL
A.	NULL
,	NULL
Metcalf	NULL
,	NULL
D.	NULL
,	NULL
Li	NULL
,	NULL
R.	NULL
,	NULL
Tarlintou	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Gerondakis	NULL
,	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Mice	NULL
lacking	NULL
the	NULL
c-rel	NULL
proto-oncogene	NULL
exhibit	NULL
defects	NULL
in	NULL
|ymphocyte	NULL
proliferation	NULL
,	NULL
humoral	NULL
immunity	NULL
,	NULL
and	NULL
interleukin-2	NULL
expression	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9	NULL
,	NULL
1965-1977	NULL
.	NULL

Kovach	NULL
,	NULL
N.L	NULL
.	NULL

,	NULL
Lindgren	NULL
,	NULL
C.G	NULL
.	NULL

,	NULL
Fefer	NULL
,	NULL
A.	NULL
,	NULL
Thompson	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
Yednock	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Harlan	NULL
,	NULL
J.M	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Pentoxifylline	NULL
inhibits	NULL
integrin-mediated	NULL
adherence	NULL
of	NULL
interleukin-2-activated	NULL
human	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
to	NULL
human	NULL
umbilical	NULL
vein	NULL
endothelial	NULL
cells	NULL
,	NULL
matrix	NULL
compo-nents	NULL
,	NULL
and	NULL
culture	NULL
tumor	NULL
cells	NULL
.	NULL

Blood	NULL
84	NULL
,	NULL
2234-2242	NULL
.	NULL

Ledebur	NULL
,	NULL
H.C.	NULL
,	NULL
and	NULL
Parks	NULL
,	NULL
T.P	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
gene	NULL
by	NULL
inflammatory	NULL
cyto-kines	NULL
in	NULL
human	NULL
endothelial	NULL
cells	NULL
:	NULL
essential	NULL
roles	NULL
of	NULL
a	NULL
variant	NULL
NF-kB	NULL
site	NULL
and	NULL
p65	NULL
homodimers	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
933-943	NULL
.	NULL

Leung	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Nabel	NULL
,	NULL
G.J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
.	NULL

HTLV-1	NULL
transactivator	NULL
induces	NULL
interleukin-2	NULL
receptor	NULL
expression	NULL
through	NULL
an	NULL
NF-	NULL
«	NULL
B-like	NULL
factor	NULL
.	NULL

Nature	NULL
333	NULL
,	NULL
776-778	NULL
.	NULL

Lowenthal	NULL
,	NULL
J.W	NULL
.	NULL

,	NULL
Ballard	NULL
,	NULL
D.W.	NULL
,	NULL
Bonhlein	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.C.	NULL
(	NULL
1989	NULL
)	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
induces	NULL
proteins	NULL
that	NULL
bind	NULL
specifically	NULL
to	NULL
«	NULL
B-like	NULL
enhancer	NULL
elements	NULL
and	NULL
regulate	NULL
interleukin-2	NULL
receptor	NULL
«	NULL
-chain	NULL
gene	NULL
expression	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86	NULL
,	NULL
2331-2335	NULL
.	NULL

Mauxion	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Sen	NULL
,	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
.	NULL

Alteration	NULL
of	NULL
a	NULL
single	NULL
nucleotide	NULL
allows	NULL
efficient	NULL
binding	NULL
of	NULL
H2TF1/kBF1	NULL
to	NULL
immunoglobulin	NULL
x	NULL
enhancer	NULL
B	NULL
motif	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
3548-3552	NULL
.	NULL

Mauxion	NULL
,	NULL
F.	NULL
,	NULL
Jamieson	NULL
,	NULL
C.	NULL
,	NULL
Yoshida	NULL
,	NULL
M.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Sen	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

Comparison	NULL
of	NULL
constitutive	NULL
and	NULL
inducible	NULL
transcriptional	NULL
enhancement	NULL
mediated	NULL
by	NULL
«	NULL
B-related	NULL
sequences	NULL
:	NULL
modulation	NULL
of	NULL
activity	NULL
in	NULL
B	NULL
cells	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
|	NULL
fax	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
,	NULL
2141-2145	NULL
.	NULL

Miller	NULL
,	NULL
J.	NULL
,	NULL
Malek	NULL
,	NULL
T.R	NULL
.	NULL

,	NULL
Leonard	NULL
,	NULL
W.J	NULL
.	NULL

,	NULL
Greene	NULL
,	NULL
W.C.	NULL
,	NULL
Shevack	NULL
,	NULL
E.M.	NULL
,	NULL
and	NULL
Germain	NULL
,	NULL
R.N	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
and	NULL
expression	NULL
of	NULL
a	NULL
mouse	NULL
interleukin	NULL
2	NULL
receptor	NULL
cDNA	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

134	NULL
,	NULL
4212-4217	NULL
.	NULL

Montgomery	NULL
,	NULL
K.F	NULL
.	NULL

,	NULL
Osborn	NULL
,	NULL
L.	NULL
,	NULL
Hession	NULL
,	NULL
C.	NULL
,	NULL
Tizard	NULL
,	NULL
R.	NULL
,	NULL
Goff	NULL
,	NULL
D.	NULL
,	NULL
Vas-sallo	NULL
,	NULL
C.	NULL
,	NULL
Tarr	NULL
,	NULL
P.J	NULL
.	NULL

,	NULL
Bomsztyk	NULL
,	NULL
K.	NULL
,	NULL
Lobb	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Harlan	NULL
,	NULL
J.M	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
endothelial-leukocyte	NULL
adhesion	NULL
molecule	NULL
1	NULL
(	NULL
ELAM-1	NULL
)	NULL
gene	NULL
transcription	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
,	NULL
6523-6527	NULL
.	NULL

Neish	NULL
,	NULL
A.S.	NULL
,	NULL
Williams	NULL
,	NULL
A.J	NULL
.	NULL

,	NULL
Palmer	NULL
,	NULL
H.J	NULL
.	NULL

,	NULL
Whiteley	NULL
,	NULL
M.Z	NULL
.	NULL

,	NULL
and	NULL
Collins	NULL
,	NULL
T.	NULL
(	NULL
1992	NULL
)	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule	NULL
1	NULL
promoter	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

176	NULL
,	NULL
1583-1593	NULL
.	NULL

Nelsen	NULL
,	NULL
B.	NULL
,	NULL
Kadesch	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Sen	NULL
,	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
.	NULL

Complex	NULL
regulation	NULL
Immunity	NULL
174	NULL
of	NULL
the	NULL
immunoglobulin	NULL
heavy-chain	NULL
gene	NULL
enhancer	NULL
:	NULL
1B	NULL
,	NULL
a	NULL
new	NULL
determinant	NULL
of	NULL
enhancer	NULL
function	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
3145-3154	NULL
.	NULL

Neuman	NULL
,	NULL
M.	NULL
,	NULL
Grieschammer	NULL
,	NULL
T.	NULL
,	NULL
Chuvpilo	NULL
,	NULL
S.	NULL
,	NULL
Kneitz	NULL
,	NULL
B.	NULL
,	NULL
Lohoff	NULL
,	NULL
M.	NULL
,	NULL
Schimpl	NULL
,	NULL
A.	NULL
,	NULL
Franza	NULL
,	NULL
B.R	NULL
.	NULL

,	NULL
and	NULL
Serfling	NULL
,	NULL
E.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

RelA/p65	NULL
is	NULL
a	NULL
molecular	NULL
target	NULL
for	NULL
the	NULL
immunosuppressive	NULL
action	NULL
of	NULL
protein	NULL
kinase	NULL
A.	NULL
EMBO	NULL
J	NULL
.	NULL

14	NULL
,	NULL
1991-2004	NULL
.	NULL

Northrop	NULL
,	NULL
J.P.	NULL
,	NULL
Ho	NULL
,	NULL
S.N	NULL
.	NULL

,	NULL
Chen	NULL
,	NULL
L.	NULL
,	NULL
Thomas	NULL
,	NULL
D.J	NULL
.	NULL

,	NULL
Timerman	NULL
,	NULL
LA	NULL
.	NULL

,	NULL
Nolan	NULL
,	NULL
G.P	NULL
.	NULL

,	NULL
Admon	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.R	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

NF-AT	NULL
components	NULL
define	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
targeted	NULL
in	NULL
T-cell	NULL
activation	NULL
.	NULL

Nature	NULL
369	NULL
,	NULL
497-502	NULL
.	NULL

Pierce	NULL
,	NULL
J.W	NULL
.	NULL

,	NULL
Jamieson	NULL
,	NULL
C.A	NULL
.	NULL

,	NULL
Ross	NULL
,	NULL
J.L	NULL
.	NULL

,	NULL
and	NULL
Sen	NULL
,	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
IL-2	NULL
receptor	NULL
«	NULL
-chain	NULL
gene	NULL
by	NULL
individual	NULL
members	NULL
of	NULL
the	NULL
rel	NULL
oncogene	NULL
family	NULL
in	NULL
association	NULL
with	NULL
serum	NULL
response	NULL
factor	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

155	NULL
,	NULL
1972-1980	NULL
.	NULL

Rao	NULL
,	NULL
K.M	NULL
.	NULL

,	NULL
Currie	NULL
,	NULL
M.S	NULL
.	NULL

,	NULL
McCachren	NULL
,	NULL
S.S.	NULL
,	NULL
and	NULL
Cohen	NULL
,	NULL
H.J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

Pentoxifylline	NULL
and	NULL
other	NULL
methyl	NULL
xanthines	NULL
inhibit	NULL
interleukin-2	NULL
receptor	NULL
expression	NULL
in	NULL
human	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
.	NULL

Immunol	NULL
.	NULL

135	NULL
,	NULL
314-325	NULL
.	NULL

Rott	NULL
,	NULL
O.	NULL
,	NULL
Cash	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Fleischer	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

Phosphodiesterase	NULL
inhibitor	NULL
pentoxifylline	NULL
,	NULL
a	NULL
selective	NULL
suppressor	NULL
of	NULL
T	NULL
helper	NULL
type	NULL
1-	NULL
but	NULL
not	NULL
type	NULL
2-associated	NULL
lymphokine	NULL
production	NULL
,	NULL
prevents	NULL
induction	NULL
of	NULL
experimental	NULL
autoimmune	NULL
encephalomyelitis	NULL
in	NULL
Lewis	NULL
rats	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

23	NULL
,	NULL
1745-1751	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
,	NULL
Poteat	NULL
,	NULL
H.	NULL
,	NULL
Tan	NULL
,	NULL
T.-H.	NULL
,	NULL
Kawakami	NULL
,	NULL
K.	NULL
,	NULL
Roeder	NULL
,	NULL
R.	NULL
,	NULL
Hasel-tine	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Rosen	NULL
,	NULL
C.	NULL
(	NULL
1988	NULL
)	NULL
.	NULL

Cellular	NULL
transcription	NULL
factors	NULL
and	NULL
regulation	NULL
of	NULL
IL-2	NULL
receptor	NULL
gene	NULL
expression	NULL
by	NULL
HTLV-I	NULL
fax	NULL
gene	NULL
product	NULL
.	NULL

Science	NULL
241	NULL
,	NULL
89-92	NULL
.	NULL

Schindler	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
Baichwal	NULL
,	NULL
V.R	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Three	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
human	NULL
E-selectin	NULL
gene	NULL
required	NULL
for	NULL
maximal	NULL
tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
-induced	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
5820-5831	NULL
.	NULL

Shirakawa	NULL
,	NULL
F.	NULL
,	NULL
Chedid	NULL
,	NULL
M.	NULL
,	NULL
Suttles	NULL
,	NULL
J.	NULL
,	NULL
Pollok	NULL
,	NULL
B.A	NULL
.	NULL

,	NULL
and	NULL
Mizel	NULL
,	NULL
S.B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
.	NULL

Interleukin	NULL
1	NULL
and	NULL
cyclic	NULL
AMP	NULL
induce	NULL
k	NULL
immunoglobulin	NULL
light-chain	NULL
expression	NULL
via	NULL
activation	NULL
of	NULL
an	NULL
NF-	NULL
«	NULL
B-like	NULL
DNA-binding	NULL
pro-tein	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
959-964	NULL
.	NULL

Sinha	NULL
,	NULL
B.	NULL
,	NULL
Semmler	NULL
,	NULL
J.	NULL
,	NULL
Eisenhut	NULL
,	NULL
T.	NULL
,	NULL
Eigler	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Endres	NULL
,	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Enhanced	NULL
tumor	NULL
necrosis	NULL
factor	NULL
suppression	NULL
and	NULL
cyclic	NULL
adenosine	NULL
monophosphate	NULL
accumulation	NULL
by	NULL
combination	NULL
of	NULL
phosphodiesterase	NULL
inhibitors	NULL
and	NULL
prostanoids	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

25	NULL
,	NULL
147-153	NULL
.	NULL

Streiter	NULL
,	NULL
R.M	NULL
.	NULL

,	NULL
Remick	NULL
,	NULL
D.G	NULL
.	NULL

,	NULL
Ward	NULL
,	NULL
P.A	NULL
.	NULL

,	NULL
Spengler	NULL
,	NULL
R.N	NULL
.	NULL

,	NULL
Lynch	NULL
,	NULL
J.P.	NULL
,	NULL
Larrick	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Kunkel	NULL
,	NULL
S.L	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
.	NULL

Cellular	NULL
and	NULL
molecular	NULL
regulation	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
production	NULL
by	NULL
pentoxifylline	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

155	NULL
,	NULL
1230-1236	NULL
.	NULL

Takahashi	NULL
,	NULL
G.W	NULL
.	NULL

,	NULL
Montgomery	NULL
,	NULL
R.B	NULL
.	NULL

,	NULL
Stahl	NULL
,	NULL
W.L	NULL
.	NULL

,	NULL
Crittenden	NULL
,	NULL
C.A	NULL
.	NULL

,	NULL
Valentine	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
Thorning	NULL
,	NULL
D.R	NULL
.	NULL

,	NULL
Andrews	NULL
,	NULL
D.V	NULL
.	NULL

,	NULL
and	NULL
Lilly	NULL
,	NULL
M.B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Pentoxifylline	NULL
inhibits	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
«	NULL
-mediated	NULL
cytotoxicity	NULL
and	NULL
cytostasis	NULL
in	NULL
L929	NULL
murine	NULL
fibrosarcoma	NULL
cells	NULL
.	NULL

Int	NULL
.	NULL

J.	NULL
Immuno-pharmacol	NULL
.	NULL

16	NULL
,	NULL
723-736	NULL
.	NULL

Timmerman	NULL
,	NULL
LA	NULL
.	NULL

,	NULL
Clipstone	NULL
,	NULL
N.A	NULL
.	NULL

,	NULL
Ho	NULL
,	NULL
S.N	NULL
.	NULL

,	NULL
Northrop	NULL
,	NULL
J.P.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.R	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Rapid	NULL
shuttling	NULL
of	NULL
NF-AT	NULL
in	NULL
discrimination	NULL
of	NULL
signals	NULL
and	NULL
immunosuppression	NULL
.	NULL

Nature	NULL
383	NULL
,	NULL
837-840	NULL
.	NULL

Tozawa	NULL
,	NULL
K.	NULL
,	NULL
Sakurada	NULL
,	NULL
S.	NULL
,	NULL
Kohri	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Okamoto	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Effects	NULL
of	NULL
anti-nuclear	NULL
factor	NULL
kB	NULL
reagents	NULL
in	NULL
blocking	NULL
adhesion	NULL
of	NULL
human	NULL
cancer	NULL
cells	NULL
to	NULL
vascular	NULL
endothelial	NULL
cells	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

55	NULL
,	NULL
4162-4267	NULL
.	NULL

Ullman	NULL
,	NULL
K.S	NULL
.	NULL

,	NULL
Northrop	NULL
,	NULL
J.P.	NULL
,	NULL
Verweij	NULL
,	NULL
C.L	NULL
.	NULL

,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.R	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
.	NULL

Transmission	NULL
of	NULL
signals	NULL
from	NULL
the	NULL
T	NULL
lymphocyte	NULL
antigen	NULL
receptor	NULL
to	NULL
the	NULL
genes	NULL
responsible	NULL
for	NULL
cell	NULL
proliferation	NULL
and	NULL
immune	NULL
function	NULL
:	NULL
the	NULL
missing	NULL
link	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

8	NULL
,	NULL
421-452	NULL
.	NULL

Utz	NULL
,	NULL
P.J	NULL
.	NULL

,	NULL
Durand	NULL
,	NULL
D.B	NULL
.	NULL

,	NULL
Toole	NULL
,	NULL
J.J.	NULL
,	NULL
Emmel	NULL
,	NULL
EA	NULL
.	NULL

,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.R	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
putative	NULL
regulator	NULL
of	NULL
early	NULL
T	NULL
cell	NULL
activation	NULL
genes	NULL
.	NULL

Science	NULL
241	NULL
,	NULL
202-205	NULL
.	NULL

Venkataraman	NULL
,	NULL
L.	NULL
,	NULL
Francis	NULL
,	NULL
D.	NULL
,	NULL
Liu	NULL
,	NULL
J.	NULL
,	NULL
Rothstein	NULL
,	NULL
T.L	NULL
.	NULL

,	NULL
and	NULL
Sen	NULL
,	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Cyclosporin-A	NULL
sensitive	NULL
induction	NULL
of	NULL
NF-AT	NULL
in	NULL
murine	NULL
B	NULL
cells	NULL
.	NULL

Immunity	NULL
1	NULL
,	NULL
189-196	NULL
.	NULL

Venkataraman	NULL
,	NULL
L.	NULL
,	NULL
Burakoff	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
and	NULL
Sen	NULL
,	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

FK506	NULL
inhibits	NULL
antigen	NULL
receptor-mediated	NULL
induction	NULL
of	NULL
c-rel	NULL
in	NULL
B	NULL
and	NULL
T	NULL
lymphoid	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181	NULL
,	NULL
1091-1099	NULL
.	NULL

Venkataraman	NULL
,	NULL
L.	NULL
,	NULL
Wang	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Sen	NULL
,	NULL
R.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

Differential	NULL
regulation	NULL
of	NULL
c-Rel	NULL
translocation	NULL
in	NULL
activated	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157	NULL
,	NULL
1149-1155	NULL
.	NULL

Verweij	NULL
,	NULL
C.L	NULL
.	NULL

,	NULL
Geerts	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Aarden	NULL
,	NULL
L.A.	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
interleukin-2	NULL
gene	NULL
transcription	NULL
via	NULL
the	NULL
T-cell	NULL
surface	NULL
molecule	NULL
CD28	NULL
is	NULL
mediated	NULL
through	NULL
an	NULL
NF-	NULL
«	NULL
B-like	NULL
response	NULL
element	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
14179-14182	NULL
.	NULL

Yang	NULL
,	NULL
K.D	NULL
.	NULL

,	NULL
Chuen	NULL
,	NULL
H.L	NULL
.	NULL

,	NULL
and	NULL
Shaio	NULL
,	NULL
M.F	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Pentoxifylline	NULL
augments	NULL
but	NULL
does	NULL
not	NULL
antagonize	NULL
TNFa-mediated	NULL
neuroblastoma	NULL
cell	NULL
differentiation	NULL
:	NULL
modulation	NULL
of	NULL
calcium	NULL
mobilization	NULL
but	NULL
not	NULL
cAMP	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

211	NULL
,	NULL
1006-1014	NULL
.	NULL

